{
  "meta": {
    "id": "test12",
    "title": "Mid Day Module (Biochemistry-3) - 2024-12-25",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A team of endocrinologists is conducting a study on the regulation of fat metabolism by various hormones. Their research focuses on the activity of hormone-sensitive lipase (HSL) in adipose tissue, a crucial enzyme in the mobilization of stored fats. Through their investigations, they aim to determine which hormone does not stimulate an increase in HSL activity. Which hormone is NOT associated with an increase in the activity of hormone-sensitive lipase in adipose tissue?",
      "options": [
        {
          "label": "A",
          "text": "Adrenaline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Growth hormone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Corticosteroids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Insulin",
          "correct": true
        }
      ],
      "correct_answer": "D. Insulin",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-121425.png"
      ],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Adrenaline : This hormone activates hormone-sensitive lipase via the cAMP signaling pathway, leading to increased lipolysis.</li><li>\u2022 Option A: Adrenaline</li><li>\u2022 activates hormone-sensitive lipase</li><li>\u2022 cAMP signaling pathway,</li><li>\u2022 increased</li><li>\u2022 lipolysis.</li><li>\u2022 Option B: Growth hormone : Growth hormone can s timulate lipolysis in adipose tissue, partly by increasing HSL activity.</li><li>\u2022 Option B: Growth hormone</li><li>\u2022 timulate lipolysis</li><li>\u2022 increasing HSL activity.</li><li>\u2022 Option C: Corticosteroids : Corticosteroids can also promote lipolysis , although their effect may be more complex and context-dependent.</li><li>\u2022 Option C: Corticosteroids</li><li>\u2022 promote lipolysis</li><li>\u2022 their effect</li><li>\u2022 more complex</li><li>\u2022 context-dependent.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Insulin is known to inhibit the activity of hormone-sensitive lipase (HSL) in adipose tissue. HSL plays a key role in the hydrolysis of stored triglycerides into free fatty acids and glycerol, a process that is suppressed by insulin . Insulin promotes fat storage by inhibiting lipolysis , in contrast to hormones like adrenaline, growth hormone, and corticosteroids, which stimulate HSL activity and promote fat breakdown.</li><li>\u27a4 Insulin is known to inhibit the activity of hormone-sensitive lipase (HSL) in adipose tissue.</li><li>\u27a4 Insulin</li><li>\u27a4 inhibit the activity of hormone-sensitive lipase (HSL)</li><li>\u27a4 adipose tissue.</li><li>\u27a4 HSL plays a key role in the hydrolysis of stored triglycerides into free fatty acids and glycerol, a process that is suppressed by insulin .</li><li>\u27a4 HSL</li><li>\u27a4 hydrolysis of stored triglycerides</li><li>\u27a4 free fatty acids</li><li>\u27a4 glycerol,</li><li>\u27a4 suppressed</li><li>\u27a4 insulin</li><li>\u27a4 Insulin promotes fat storage by inhibiting lipolysis , in contrast to hormones like adrenaline, growth hormone, and corticosteroids, which stimulate HSL activity and promote fat breakdown.</li><li>\u27a4 Insulin</li><li>\u27a4 fat storage</li><li>\u27a4 inhibiting lipolysis</li><li>\u27a4 adrenaline, growth hormone, and</li><li>\u27a4 corticosteroids,</li><li>\u27a4 stimulate HSL activity</li><li>\u27a4 promote fat breakdown.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 159</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 159</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f2152fdd",
      "audio": ""
    },
    {
      "text": "In a pediatric clinic, a physician evaluates a 7-month-old male infant presented by his mother with concerns about hypotonia, hepatomegaly, and delayed developmental milestones. Suspecting Zellweger syndrome, a peroxisomal disorder, the physician considers the metabolic abnormalities associated with this condition. Which type of fatty acids is known to accumulate in patients with Zellweger syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Short chain fatty acids",
          "correct": false
        },
        {
          "label": "B",
          "text": "Long chain fatty acids",
          "correct": false
        },
        {
          "label": "C",
          "text": "Medium chain fatty acids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Very long chain fatty acids",
          "correct": true
        }
      ],
      "correct_answer": "D. Very long chain fatty acids",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Zellweger syndrome is a peroxisomal disorder characterized by the absence or malfunction of peroxisomes in the cells. One of the key functions of peroxisomes is the \u03b2-oxidation of very long chain fatty acids (VLCFAs). In Zellweger syndrome , the inability to metabolize VLCFAs leads to their accumulation in tissues and blood, contributing to the clinical manifestations of the disorder.</li><li>\u27a4 Zellweger syndrome</li><li>\u27a4 peroxisomal</li><li>\u27a4 absence or malfunction of peroxisomes</li><li>\u27a4 peroxisomes is the \u03b2-oxidation of very long chain fatty acids (VLCFAs).</li><li>\u27a4 Zellweger syndrome</li><li>\u27a4 inability to</li><li>\u27a4 metabolize VLCFAs</li><li>\u27a4 accumulation in tissues and blood,</li><li>\u27a4 clinical manifestations of the disorder.</li><li>\u27a4 Ref : Harper 30/e: p 241,614</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 241,614</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2f2ee7a2",
      "audio": ""
    },
    {
      "text": "In a pediatric clinic, a teenage girl presents with complaints of fatigue and muscle weakness. After conducting lab tests, the diagnosis points towards a carnitine deficiency. The attending physician explains to the girl and her parents about carnitine's role and its characteristics. Which of the following statements about carnitine is correct?",
      "options": [
        {
          "label": "A",
          "text": "It is synthesized from lysine and methionine in liver and kidney",
          "correct": true
        },
        {
          "label": "B",
          "text": "It is chemically Beta-hydroxy Gamma-Trimethyl amino butyrate",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is a transporter for short chain fatty acids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vitamin B12 is essential for its synthesis",
          "correct": false
        }
      ],
      "correct_answer": "A. It is synthesized from lysine and methionine in liver and kidney",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) It is synthesized from lysine and methionine in the liver and kidney.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. It is chemically Beta-hydroxy Gamma-Trimethyl amino butyrate : This statement is a correct description of the chemical structure of carnitine , indicating that this option could also be considered correct.</li><li>\u2022 Option B. It is chemically Beta-hydroxy Gamma-Trimethyl amino butyrate</li><li>\u2022 correct</li><li>\u2022 chemical</li><li>\u2022 structure of carnitine</li><li>\u2022 correct.</li><li>\u2022 Option C. It is a transporter for short chain fatty acids : Carnitine primarily facilitates the transport of long-chain fatty acids into mitochondria for oxidation , not short-chain fatty acids.</li><li>\u2022 Option C. It is a transporter for short chain fatty acids</li><li>\u2022 Carnitine</li><li>\u2022 facilitates</li><li>\u2022 long-chain fatty acids</li><li>\u2022 mitochondria for oxidation</li><li>\u2022 not</li><li>\u2022 Option D. Vitamin B12 is essential for its synthesis : While vitamin B12 is essential for many metabolic processes , it is not directly involved in the synthesis of carnitine . The synthesis of carnitine requires lysine, methionine, and other cofactors like vitamin C, but not vitamin B12.</li><li>\u2022 Option D. Vitamin B12 is essential for its synthesis</li><li>\u2022 vitamin B12</li><li>\u2022 metabolic processes</li><li>\u2022 not</li><li>\u2022 synthesis of carnitine</li><li>\u2022 synthesis of carnitine</li><li>\u2022 lysine, methionine, and other cofactors like vitamin C,</li><li>\u2022 not vitamin B12.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Carnitine, synthesized from lysine and methionine in the liver and kidneys , is essential for the transport of long-chain fatty acids into mitochondria for \u03b2-oxidation</li><li>\u27a4 Carnitine, synthesized from lysine and methionine in the liver and kidneys</li><li>\u27a4 transport of long-chain fatty acids</li><li>\u27a4 mitochondria for \u03b2-oxidation</li><li>\u27a4 Ref : Harper30/e pg 224, Vasudevan 9/ed:p202</li><li>\u27a4 Ref</li><li>\u27a4 : Harper30/e pg 224, Vasudevan 9/ed:p202</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "303c8b78",
      "audio": ""
    },
    {
      "text": "What is this difference in the production of byproducts between beta-oxidation in peroxisomes and that in mitochondria?",
      "options": [
        {
          "label": "A",
          "text": "H2O2",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acetyl CoA",
          "correct": false
        },
        {
          "label": "C",
          "text": "Different enzymes are found in different site",
          "correct": false
        },
        {
          "label": "D",
          "text": "NADH is required",
          "correct": false
        }
      ],
      "correct_answer": "A. H2O2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Acetyl CoA : Both peroxisomal and mitochondrial beta-oxidation generate acetyl CoA , so this is not a distinguishing feature.</li><li>\u2022 Option B: Acetyl CoA</li><li>\u2022 Both peroxisomal and mitochondrial beta-oxidation</li><li>\u2022 acetyl CoA</li><li>\u2022 not</li><li>\u2022 Option C: Different enzymes are found in different sites : While it's true that different enzymes catalyze the steps of beta-oxidation in peroxisomes and mitochondria , this option does not refer to a unique byproduct of the reaction .</li><li>\u2022 Option C: Different enzymes are found in different sites</li><li>\u2022 true that different enzymes catalyze</li><li>\u2022 beta-oxidation in peroxisomes and mitochondria</li><li>\u2022 not</li><li>\u2022 unique byproduct</li><li>\u2022 reaction</li><li>\u2022 Option D: NADH is required : NADH is a product of mitochondrial beta-oxidation where it is later used in the electron transport chain to generate ATP . Peroxisomal oxidation does not contribute directly to the electron transport chain and therefore the role of NADH in peroxisomal beta-oxidation is not a key distinguishing feature in the context of byproduct production.</li><li>\u2022 Option D: NADH is required</li><li>\u2022 mitochondrial beta-oxidation</li><li>\u2022 used in the electron transport chain</li><li>\u2022 ATP</li><li>\u2022 Peroxisomal oxidation</li><li>\u2022 not</li><li>\u2022 electron</li><li>\u2022 NADH</li><li>\u2022 peroxisomal beta-oxidation</li><li>\u2022 not</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A modified beta-oxidation pathway takes place in peroxisomes for fatty Acids > C20, C22 (VLCFs) Oxidation in the Peroxisomes \u2192 produces Acetyl CoA and H2O2 (instead of FADH2) No ATP is generated. Further oxidation of Acetyl CoA and Octanoyl CoA takes place in the mitochondria .</li><li>\u27a4 A modified beta-oxidation pathway takes place in peroxisomes for fatty Acids > C20, C22 (VLCFs)</li><li>\u27a4 modified beta-oxidation pathway</li><li>\u27a4 peroxisomes for fatty Acids</li><li>\u27a4 C20, C22 (VLCFs)</li><li>\u27a4 Oxidation in the Peroxisomes \u2192 produces Acetyl CoA and H2O2 (instead of FADH2)</li><li>\u27a4 Oxidation</li><li>\u27a4 Peroxisomes</li><li>\u27a4 Acetyl CoA and H2O2</li><li>\u27a4 No ATP is generated.</li><li>\u27a4 No ATP</li><li>\u27a4 Further oxidation of Acetyl CoA and Octanoyl CoA takes place in the mitochondria .</li><li>\u27a4 Further oxidation</li><li>\u27a4 Acetyl CoA and Octanoyl CoA</li><li>\u27a4 mitochondria</li><li>\u27a4 Ref : Harper 30/e page 226</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e page 226</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "db0e1c67",
      "audio": ""
    },
    {
      "text": "A neurologist is assessing a teenage girl who has been experiencing fatigue severe enough to prevent her participation in physical education classes. She presents with muscle weakness in her limbs. Lab tests indicate high serum levels of triacylglycerols esterified with long-chain fatty acids (LCFAs) and hypoglycemia. A muscle biopsy shows an abundance of lipid vacuoles. What condition do these clinical findings suggest?",
      "options": [
        {
          "label": "A",
          "text": "Carnitine deficiency",
          "correct": true
        },
        {
          "label": "B",
          "text": "Fatty acid synthase deficiency",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tay-Sachs disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Biotin deficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Carnitine deficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Affects the de novo synthesis of fatty acids occurs in the cytoplasm with the help of a dimeric multi-enzyme complex termed Fatty acid synthase .</li><li>\u2022 Option B:</li><li>\u2022 de novo synthesis</li><li>\u2022 fatty acids</li><li>\u2022 cytoplasm</li><li>\u2022 dimeric multi-enzyme complex</li><li>\u2022 Fatty acid synthase</li><li>\u2022 Option C: Deficiency of hexosaminidase A leads to accumulation of Ganglioside (GM2). C/F - Mental retardation, Cherry red spot in the macula with Progressive deterioration and death by 3\u20134 years.</li><li>\u2022 Option C:</li><li>\u2022 Deficiency of hexosaminidase A</li><li>\u2022 Ganglioside (GM2). C/F</li><li>\u2022 Mental retardation, Cherry red spot in the macula</li><li>\u2022 death by 3\u20134 years.</li><li>\u2022 Option D: Biotin deficiency includes dermatitis, atrophic glossitis, hyperesthesia, muscle pain, anorexia and hallucinations .</li><li>\u2022 Option D:</li><li>\u2022 dermatitis, atrophic glossitis, hyperesthesia, muscle pain, anorexia</li><li>\u2022 hallucinations</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The clinical manifestations of carnitine deficiency , including muscle weakness, elevated serum triacylglycerols with LCFAs, hypoglycemia , and lipid accumulation in muscle cells , which reflect the impaired transport of fatty acids into mitochondria for \u03b2-oxidation .</li><li>\u27a4 carnitine deficiency</li><li>\u27a4 muscle weakness, elevated serum triacylglycerols</li><li>\u27a4 LCFAs, hypoglycemia</li><li>\u27a4 lipid accumulation in muscle cells</li><li>\u27a4 impaired transport</li><li>\u27a4 fatty acids</li><li>\u27a4 \u03b2-oxidation</li><li>\u27a4 Ref : Harper 30/e:p 224,231.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:p 224,231.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e9e91069",
      "audio": ""
    },
    {
      "text": "A 62-year-old man from Africa with a history of diabetes presents with severe vomiting, epigastric pain, and confusion. He has been using local herbal remedies to manage his blood sugar for the last 8 months and is concerned about possible overconsumption. On examination, he is comatose, dehydrated, and shows signs of tachycardia and tachypnea. Laboratory tests reveal hypoglycemia at 53 mg/dl and a significant electrolyte imbalance. His urine is positive for a high amount of dicarboxylic acid?",
      "options": [
        {
          "label": "A",
          "text": "Jamaican Vomiting Sickness",
          "correct": true
        },
        {
          "label": "B",
          "text": "Zellweger syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carnitine deficiency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Propionyl CoA carboxylase deficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Jamaican Vomiting Sickness",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ac0689eb",
      "audio": ""
    },
    {
      "text": "A 45-year-old man presents to the clinic with progressive difficulty in night vision and a recent history of unsteady gait. He reports no significant medical history except for a strict vegetarian diet for many years. Physical examination reveals mild hepatomegaly and decreased ankle reflexes. Laboratory tests show elevated plasma levels of a specific fatty acid. The patient\u2019s condition is suspected to be due to a metabolic disorder affecting fatty acid catabolism:",
      "options": [
        {
          "label": "A",
          "text": "Accumulation of phytanic acid",
          "correct": true
        },
        {
          "label": "B",
          "text": "Formation of dicarboxylic acid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Formation of propionyl CoA",
          "correct": false
        },
        {
          "label": "D",
          "text": "Formation of acetyl CoA",
          "correct": false
        }
      ],
      "correct_answer": "A. Accumulation of phytanic acid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Formation of dicarboxylic acid : Dicarboxylic acids accumulate as a result of \u03c9-oxidation, which typically occurs when \u03b2-oxidation is impaired, not \u03b1-oxidation.</li><li>\u2022 Option B: Formation of dicarboxylic acid</li><li>\u2022 \u03c9-oxidation,</li><li>\u2022 \u03b2-oxidation is impaired, not</li><li>\u2022 Option C: Formation of propionyl CoA : Propionyl CoA is a product of the \u03b2-oxidation of odd-chain fatty acids , not related to \u03b1-oxidation defects .</li><li>\u2022 Option C: Formation of propionyl CoA</li><li>\u2022 \u03b2-oxidation</li><li>\u2022 odd-chain fatty acids</li><li>\u2022 not</li><li>\u2022 \u03b1-oxidation defects</li><li>\u2022 Option D: Formation of acetyl CoA : Acetyl CoA is a product of \u03b2-oxidation of fatty acids . Lack of \u03b1-oxidation does not directly lead to the formation of acetyl CoA.</li><li>\u2022 Option D: Formation of acetyl CoA</li><li>\u2022 Acetyl CoA</li><li>\u2022 \u03b2-oxidation of fatty acids</li><li>\u2022 Lack</li><li>\u2022 \u03b1-oxidation</li><li>\u2022 not</li><li>\u2022 acetyl CoA.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lack of \u03b1-oxidation of fatty acids leads to the accumulation of phytanic acid , a branched-chain fatty acid derived mainly from dietary sources , particularly ruminant fats . Humans lack the enzymes to introduce a double bond in phytanic acid , making \u03b1-oxidation necessary for its catabolism . Deficiencies in this pathway, such as in Refsum disease , lead to the accumulation of phytanic acid , which is toxic to cells and can cause symptoms like night blindness, ataxia, and peripheral neuropathy.</li><li>\u27a4 Lack</li><li>\u27a4 \u03b1-oxidation of fatty acids</li><li>\u27a4 phytanic acid</li><li>\u27a4 branched-chain fatty acid</li><li>\u27a4 dietary sources</li><li>\u27a4 ruminant fats</li><li>\u27a4 lack</li><li>\u27a4 double bond</li><li>\u27a4 phytanic acid</li><li>\u27a4 \u03b1-oxidation</li><li>\u27a4 its catabolism</li><li>\u27a4 Deficiencies</li><li>\u27a4 Refsum disease</li><li>\u27a4 phytanic acid</li><li>\u27a4 toxic</li><li>\u27a4 night blindness, ataxia, and peripheral neuropathy.</li><li>\u27a4 Ref : Harper 30/ed ,pg 231</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/ed ,pg 231</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c33c973",
      "audio": ""
    },
    {
      "text": "Identify an incorrect statement about omega-oxidation of fatty acids:",
      "options": [
        {
          "label": "A",
          "text": "Takes place in mitochondria",
          "correct": true
        },
        {
          "label": "B",
          "text": "Produce dicarboxylic acids",
          "correct": false
        },
        {
          "label": "C",
          "text": "NADPH and cytochrome P-450 play a role",
          "correct": false
        },
        {
          "label": "D",
          "text": "Involves methyl group at omega end",
          "correct": false
        }
      ],
      "correct_answer": "A. Takes place in mitochondria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Omega-oxidation of fatty acids takes place primarily in the endoplasmic reticulum of cells, not in mitochondria . This pathway serves as an alternative to the \u03b2-oxidation of fatty acids , which occurs in mitochondria and peroxisomes.</li><li>\u27a4 Omega-oxidation of fatty acids</li><li>\u27a4 endoplasmic reticulum</li><li>\u27a4 not in mitochondria</li><li>\u27a4 alternative to the \u03b2-oxidation of fatty acids</li><li>\u27a4 mitochondria and peroxisomes.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 205</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3dc9e170",
      "audio": ""
    },
    {
      "text": "A 35-year-old man has been observing a fast as part of a cultural festival for several days. Despite significantly reduced food intake, he surprisingly reports feeling mentally alert and does not experience any dizziness or significant discomfort typically associated with low blood sugar levels. Intrigued by this adaptation, he visits a healthcare provider for a routine check-up. The provider explains how the body adapts to prolonged fasting by utilizing alternative energy sources to maintain brain function and overall metabolism:",
      "options": [
        {
          "label": "A",
          "text": "Coenzyme A",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beta-carotene",
          "correct": false
        },
        {
          "label": "C",
          "text": "Beta-hydroxybutyrate",
          "correct": true
        },
        {
          "label": "D",
          "text": "Apoprotein",
          "correct": false
        }
      ],
      "correct_answer": "C. Beta-hydroxybutyrate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 During prolonged fasting , the body shifts to ketosis , a metabolic state where it uses ketone bodies as an alternative energy source. Beta-hydroxybutyrate is one of the primary ketone bodies produced by the liver from fatty acids in the absence of sufficient glucose. The brain can utilize beta-hydroxybutyrate efficiently in place of glucose, allowing for sustained cognitive function and energy levels despite low blood glucose.</li><li>\u27a4 prolonged fasting</li><li>\u27a4 body shifts to ketosis</li><li>\u27a4 metabolic state</li><li>\u27a4 ketone bodies</li><li>\u27a4 alternative energy source.</li><li>\u27a4 Beta-hydroxybutyrate</li><li>\u27a4 primary ketone bodies</li><li>\u27a4 liver from fatty acids</li><li>\u27a4 absence</li><li>\u27a4 glucose.</li><li>\u27a4 brain can utilize beta-hydroxybutyrate</li><li>\u27a4 glucose,</li><li>\u27a4 sustained</li><li>\u27a4 cognitive function</li><li>\u27a4 energy levels</li><li>\u27a4 low blood glucose.</li><li>\u27a4 Ref : Harper 30/e: p 148-149.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 148-149.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9175a891",
      "audio": ""
    },
    {
      "text": "A teenage boy, self-conscious about his weight, decides to follow a fat-free diet in hopes of improving his physique. After adhering to this dietary regimen for several weeks, he visits a nutritionist for a consultation. Concerned about potential nutritional deficiencies and their impact on lipid metabolism, the nutritionist reviews the boy's diet and decides to assess his body's ability to synthesize various essential lipids that might be affected by his restrictive diet:",
      "options": [
        {
          "label": "A",
          "text": "Cholesterol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prostaglandins",
          "correct": true
        },
        {
          "label": "C",
          "text": "Glycolipids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phospholipids",
          "correct": false
        }
      ],
      "correct_answer": "B. Prostaglandins",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)\u00a0Prostaglandins</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prostaglandins are synthesized from arachidonic acid. Arachidonic acid is synthesized from linoleic acid, which is an essential fatty acid supplied from dietary lipids in adequate amounts.</li><li>\u27a4 Prostaglandins are synthesized from arachidonic acid.</li><li>\u27a4 Prostaglandins are synthesized from arachidonic acid.</li><li>\u27a4 Prostaglandins</li><li>\u27a4 synthesized</li><li>\u27a4 arachidonic acid.</li><li>\u27a4 Arachidonic acid is synthesized from linoleic acid, which is an essential fatty acid supplied from dietary lipids in adequate amounts.</li><li>\u27a4 Arachidonic acid is synthesized from linoleic acid, which is an essential fatty acid supplied from dietary lipids in adequate amounts.</li><li>\u27a4 Arachidonic acid</li><li>\u27a4 synthesized</li><li>\u27a4 linoleic acid,</li><li>\u27a4 essential fatty acid</li><li>\u27a4 dietary lipids</li><li>\u27a4 adequate amounts.</li><li>\u27a4 Ref : Harper 30/e: p 213-215, 238-240.</li><li>\u27a4 Ref : Harper 30/e: p 213-215, 238-240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9d59af94",
      "audio": ""
    },
    {
      "text": "Match the following enzymes with the pathway they are involved in:",
      "options": [
        {
          "label": "A",
          "text": "1-b, 2-a, 3-d, 4-c",
          "correct": true
        },
        {
          "label": "B",
          "text": "1-b, 2-d, 3-a, 4-c",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-a, 2-b, 3-c, 4-d",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-d, 2-a, 3-b, 4-c",
          "correct": false
        }
      ],
      "correct_answer": "A. 1-b, 2-a, 3-d, 4-c",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-160529.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-160656.png"
      ],
      "explanation": "<p><strong>Ans. A)\u00a01-b, 2-a, 3-d, 4-c</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 HMG CoA Reductase is a key enzyme in the biosynthesis of cholesterol , catalyzing the conversion of HMG-CoA to mevalonate , a rate-limiting step in cholesterol synthesis. Hence, 1-b is correct . 7-alpha-hydroxylase is the rate-limiting enzyme in the formation of bile acids from cholesterol . It catalyzes the introduction of a hydroxyl group at the 7th position of the steroid nucleus of cholesterol, which is the first step in the classical pathway of bile acid synthesis . Thus, 2-a is correct. Thiophorase , also known as succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT), is involved in ketolysis, particularly in the utilization of ketone bodies by the tissues outside the liver, converting acetoacetate into acetoacetyl-CoA. Therefore, 3-d is accurate. Carnitine acyl transferase I is a crucial enzyme in the beta-oxidation of fatty acids . It facilitates the transport of fatty acids into the mitochondria for oxidation by converting them into their acyl-carnitine derivatives , which can cross the mitochondrial membrane . Hence, 4-c is correct.</li><li>\u2022 HMG CoA Reductase is a key enzyme in the biosynthesis of cholesterol , catalyzing the conversion of HMG-CoA to mevalonate , a rate-limiting step in cholesterol synthesis. Hence, 1-b is correct .</li><li>\u2022 HMG CoA Reductase is a key enzyme in the biosynthesis of cholesterol , catalyzing the conversion of HMG-CoA to mevalonate , a rate-limiting step in cholesterol synthesis. Hence, 1-b is correct .</li><li>\u2022 HMG CoA Reductase</li><li>\u2022 biosynthesis of cholesterol</li><li>\u2022 catalyzing</li><li>\u2022 HMG-CoA to mevalonate</li><li>\u2022 rate-limiting step</li><li>\u2022 cholesterol synthesis.</li><li>\u2022 1-b is correct</li><li>\u2022 7-alpha-hydroxylase is the rate-limiting enzyme in the formation of bile acids from cholesterol . It catalyzes the introduction of a hydroxyl group at the 7th position of the steroid nucleus of cholesterol, which is the first step in the classical pathway of bile acid synthesis . Thus, 2-a is correct.</li><li>\u2022 7-alpha-hydroxylase is the rate-limiting enzyme in the formation of bile acids from cholesterol . It catalyzes the introduction of a hydroxyl group at the 7th position of the steroid nucleus of cholesterol, which is the first step in the classical pathway of bile acid synthesis . Thus, 2-a is correct.</li><li>\u2022 7-alpha-hydroxylase</li><li>\u2022 rate-limiting enzyme</li><li>\u2022 bile acids from cholesterol</li><li>\u2022 catalyzes</li><li>\u2022 hydroxyl group</li><li>\u2022 7th position</li><li>\u2022 steroid</li><li>\u2022 cholesterol,</li><li>\u2022 first</li><li>\u2022 classical pathway</li><li>\u2022 bile acid synthesis</li><li>\u2022 2-a is correct.</li><li>\u2022 Thiophorase , also known as succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT), is involved in ketolysis, particularly in the utilization of ketone bodies by the tissues outside the liver, converting acetoacetate into acetoacetyl-CoA. Therefore, 3-d is accurate.</li><li>\u2022 Thiophorase , also known as succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT), is involved in ketolysis, particularly in the utilization of ketone bodies by the tissues outside the liver, converting acetoacetate into acetoacetyl-CoA. Therefore, 3-d is accurate.</li><li>\u2022 Thiophorase</li><li>\u2022 succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT),</li><li>\u2022 ketolysis,</li><li>\u2022 utilization of ketone bodies</li><li>\u2022 tissues</li><li>\u2022 outside</li><li>\u2022 liver,</li><li>\u2022 acetoacetate into acetoacetyl-CoA.</li><li>\u2022 3-d is accurate.</li><li>\u2022 Carnitine acyl transferase I is a crucial enzyme in the beta-oxidation of fatty acids . It facilitates the transport of fatty acids into the mitochondria for oxidation by converting them into their acyl-carnitine derivatives , which can cross the mitochondrial membrane . Hence, 4-c is correct.</li><li>\u2022 Carnitine acyl transferase I is a crucial enzyme in the beta-oxidation of fatty acids . It facilitates the transport of fatty acids into the mitochondria for oxidation by converting them into their acyl-carnitine derivatives , which can cross the mitochondrial membrane . Hence, 4-c is correct.</li><li>\u2022 Carnitine acyl transferase I</li><li>\u2022 beta-oxidation of fatty acids</li><li>\u2022 facilitates</li><li>\u2022 transport of fatty</li><li>\u2022 acids</li><li>\u2022 mitochondria</li><li>\u2022 oxidation</li><li>\u2022 converting</li><li>\u2022 acyl-carnitine derivatives</li><li>\u2022 cross</li><li>\u2022 mitochondrial membrane</li><li>\u2022 4-c</li><li>\u2022 correct.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 172,178</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 172,178</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e0057ab",
      "audio": ""
    },
    {
      "text": "Which of the following statements about the malate-aspartate shuttle is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "It is used to transport NADH from Cytosol to Mitochondria.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is used to transport NADPH from Cytoplasm to Mitochondria.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Malate get converted to Oxaloacetate and release NADH",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oxaloacetate is reconstituted from Aspartate and \u03b1 Ketoglutarate",
          "correct": false
        }
      ],
      "correct_answer": "B. It is used to transport NADPH from Cytoplasm to Mitochondria.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The malate-aspartate shuttle is a key biochemical system that allows the transfer of reducing equivalents (NADH) from the cytosol into the mitochondrial matrix, because the inner mitochondrial membrane is impermeable to NADH itself.</li><li>\u2022 How it works:</li><li>\u2022 How it works:</li><li>\u2022 In the cytosol: Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH. Malate is transported into the mitochondria. In the mitochondria: Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria. OAA is transaminated to aspartate, which can travel back to the cytosol to complete the cycle.</li><li>\u2022 In the cytosol: Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.</li><li>\u2022 Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.</li><li>\u2022 Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.</li><li>\u2022 Malate is transported into the mitochondria.</li><li>\u2022 In the mitochondria: Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.</li><li>\u2022 Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.</li><li>\u2022 Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.</li><li>\u2022 OAA is transaminated to aspartate, which can travel back to the cytosol to complete the cycle.</li><li>\u2022 Other Option:</li><li>\u2022 Other Option:</li><li>\u2022 Option A. It is used to transport NADH from Cytosol to Mitochondria : True. This is the core purpose of the shuttle. Option B. It is used to transport NADPH from Cytoplasm to Mitochondria : False. The shuttle transports NADH equivalents, not NADPH. NADPH is involved mainly in biosynthesis and antioxidant defenses, not in this shuttle system. Option C. Malate gets converted to Oxaloacetate and releases NADH : True. Inside mitochondria, malate \u2192 OAA + NADH (via malate dehydrogenase). Option D. Oxaloacetate is reconstituted from Aspartate and \u03b1-Ketoglutarate : True. Aspartate + \u03b1-KG \u2194 OAA + glutamate (via transamination).</li><li>\u2022 Option A. It is used to transport NADH from Cytosol to Mitochondria : True. This is the core purpose of the shuttle.</li><li>\u2022 Option A. It is used to transport NADH from Cytosol to Mitochondria</li><li>\u2022 Option B. It is used to transport NADPH from Cytoplasm to Mitochondria : False. The shuttle transports NADH equivalents, not NADPH. NADPH is involved mainly in biosynthesis and antioxidant defenses, not in this shuttle system.</li><li>\u2022 Option B. It is used to transport NADPH from Cytoplasm to Mitochondria</li><li>\u2022 Option C. Malate gets converted to Oxaloacetate and releases NADH : True. Inside mitochondria, malate \u2192 OAA + NADH (via malate dehydrogenase).</li><li>\u2022 Option C. Malate gets converted to Oxaloacetate and releases NADH</li><li>\u2022 Option D. Oxaloacetate is reconstituted from Aspartate and \u03b1-Ketoglutarate : True. Aspartate + \u03b1-KG \u2194 OAA + glutamate (via transamination).</li><li>\u2022 Option D. Oxaloacetate is reconstituted from Aspartate and \u03b1-Ketoglutarate</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objectives:</li><li>\u27a4 The malate-aspartate shuttle transfers cytosolic NADH equivalents into the mitochondria for oxidative phosphorylation . It operates via a series of reversible reactions , involving: Oxaloacetate \u2192 Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate \u2192 Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  \u2194 aspartate + \u03b1-ketoglutarate</li><li>\u27a4 The malate-aspartate shuttle transfers cytosolic NADH equivalents into the mitochondria for oxidative phosphorylation .</li><li>\u27a4 malate-aspartate shuttle</li><li>\u27a4 cytosolic NADH equivalents</li><li>\u27a4 oxidative phosphorylation</li><li>\u27a4 It operates via a series of reversible reactions , involving: Oxaloacetate \u2192 Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate \u2192 Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  \u2194 aspartate + \u03b1-ketoglutarate</li><li>\u27a4 series of reversible reactions</li><li>\u27a4 Oxaloacetate \u2192 Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate \u2192 Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  \u2194 aspartate + \u03b1-ketoglutarate</li><li>\u27a4 Oxaloacetate \u2192 Malate (reduced by cytosolic NADH)</li><li>\u27a4 Oxaloacetate \u2192 Malate</li><li>\u27a4 Malate transport into mitochondria</li><li>\u27a4 Malate transport</li><li>\u27a4 Malate \u2192 Oxaloacetate (regenerates NADH in matrix)</li><li>\u27a4 Malate \u2192 Oxaloacetate</li><li>\u27a4 Transamination of oxaloacetate+ Glutamate  \u2194 aspartate + \u03b1-ketoglutarate</li><li>\u27a4 Transamination</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 219.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1e0ff609",
      "audio": ""
    },
    {
      "text": "A 25-year-old man presents to the neurology clinic with a history of progressive vision loss and a family history of similar symptoms. Genetic testing reveals a mutation affecting the electron transport chain, specifically in the NADH-Q reductase (Complex I). Which of the following conditions is most likely associated with this mutation?",
      "options": [
        {
          "label": "A",
          "text": "Amyotrophic lateral sclerosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leber\u2019s optic myopathy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ragged red fibre disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Duchenne muscular dystrophy",
          "correct": false
        }
      ],
      "correct_answer": "B. Leber\u2019s optic myopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Leber\u2019s optic myopathy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Amyotrophic lateral sclerosis: This is a progressive neurodegenerative disorder affecting motor neurons but is not typically associated with mutations in NADH-Q reductase.</li><li>\u2022 Option A. Amyotrophic lateral sclerosis:</li><li>\u2022 progressive neurodegenerative disorder</li><li>\u2022 motor neurons</li><li>\u2022 not</li><li>\u2022 mutations in NADH-Q reductase.</li><li>\u2022 Option C. Ragged red fibre disease: Also known as mitochondrial myopathy , this condition is characterized by muscle weakness and the p resence of ragged red fibers in muscle biopsies . It can be associated with various mitochondrial defects but is not specifically linked to mutations in NADH-Q reductase.</li><li>\u2022 Option C. Ragged red fibre disease:</li><li>\u2022 mitochondrial myopathy</li><li>\u2022 muscle weakness</li><li>\u2022 resence of ragged red fibers</li><li>\u2022 muscle biopsies</li><li>\u2022 various mitochondrial defects</li><li>\u2022 not</li><li>\u2022 linked</li><li>\u2022 mutations in NADH-Q reductase.</li><li>\u2022 Option D. Duchenne muscular dystrophy: This is a genetic disorder characterized by progressive muscle degeneration and weakness due to mutations in the dystrophin gene, not directly related to mitochondrial function or NADH-Q reductase mutations.</li><li>\u2022 Option D. Duchenne muscular dystrophy:</li><li>\u2022 genetic disorder</li><li>\u2022 progressive muscle degeneration and weakness</li><li>\u2022 mutations in the dystrophin gene, not</li><li>\u2022 mitochondrial function or NADH-Q reductase mutations.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mutations in mitochondrial DNA causes:</li><li>\u27a4 Mutations in mitochondrial DNA causes:</li><li>\u27a4 Lethal infantile mitochondrial ophthalmoplegia Leber\u2019s hereditary optic neuropathy (LHON) Myoclonic epilepsy Mitochondrial encephalomyopathy lactic acidosis stroke like episodes (MELAS) MERRF Kearns-Sayre syndrome Pearson syndrome Leigh syndrome NARP</li><li>\u27a4 Lethal infantile mitochondrial ophthalmoplegia</li><li>\u27a4 Leber\u2019s hereditary optic neuropathy (LHON)</li><li>\u27a4 Myoclonic epilepsy</li><li>\u27a4 Mitochondrial encephalomyopathy lactic acidosis stroke like episodes (MELAS)</li><li>\u27a4 MERRF</li><li>\u27a4 Kearns-Sayre syndrome</li><li>\u27a4 Pearson syndrome</li><li>\u27a4 Leigh syndrome</li><li>\u27a4 NARP</li><li>\u27a4 Mitochondrial DNA Mutations are inherited maternally ( mother to all children ) Leber\u2019s hereditary optic myopathy is characterized by blindness in young males and caused by a single base mutation in NADH Coenzyme Q reductase.</li><li>\u27a4 Mitochondrial DNA Mutations</li><li>\u27a4 inherited maternally</li><li>\u27a4 mother to all children</li><li>\u27a4 Leber\u2019s hereditary optic myopathy</li><li>\u27a4 blindness in young males</li><li>\u27a4 single base mutation</li><li>\u27a4 NADH</li><li>\u27a4 Coenzyme Q reductase.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 358</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 358</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f71e6b0c",
      "audio": ""
    },
    {
      "text": "A child was recently diagnosed with G6PD deficiency. Glucose 6-phosphate dehydrogenase (G6PD) catalyzes the regulatory step in the HMP shunt. Which is the correct statement about G6PD and HMP shunt?",
      "options": [
        {
          "label": "A",
          "text": "Deficiency of G6PD occurs only in red blood cells.",
          "correct": false
        },
        {
          "label": "B",
          "text": "The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Deficiency of G6PD \u2192 inability to keep glutathione in reduced functional form.",
          "correct": true
        },
        {
          "label": "D",
          "text": "The reduced NADPH formed during the shunt is utilized in fatty acid oxidation.",
          "correct": false
        }
      ],
      "correct_answer": "C. Deficiency of G6PD \u2192 inability to keep glutathione in reduced functional form.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture8.jpg"
      ],
      "explanation": "<p><strong>Ans. C)\u00a0 Deficiency of G6PD \u2192 inability to keep glutathione in reduced functional form.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Deficiency of G6PD occurs only in red blood cells: The oxidative phase of the pathway is seen in Liver, Adipose tissue, Adrenal cortex, Testes and ovaries, RBCs and Lens of eye. The non-oxidative phase is present in all tissues .</li><li>\u2022 Option A. Deficiency of G6PD occurs only in red blood cells:</li><li>\u2022 oxidative phase</li><li>\u2022 Liver, Adipose tissue,</li><li>\u2022 Adrenal cortex, Testes and ovaries, RBCs and Lens of eye.</li><li>\u2022 non-oxidative phase</li><li>\u2022 all tissues</li><li>\u2022 Option B. The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions: involves two irreversible oxidative reactions</li><li>\u2022 Option B. The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions:</li><li>\u2022 two irreversible oxidative reactions</li><li>\u2022 Option D.  The reduced NADPH formed during the shunt is utilized in fatty acid oxidation: used in fatty acid synthesis, steroid hormone, and cholesterol synthesis.</li><li>\u2022 Option D.  The reduced NADPH formed during the shunt is utilized in fatty acid oxidation:</li><li>\u2022 fatty acid synthesis, steroid hormone, and cholesterol synthesis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 G6PD is an enzyme in the hexose monophosphate shunt that is responsible for the production of NADPH. NADPH is crucial for maintaining the reduced form of glutathione , a critical antioxidant in cells. In G6PD deficiency, the reduced production of NADPH leads to a reduced ability to maintain glutathione in its reduced form , making red blood cells more susceptible to oxidative damage .</li><li>\u27a4 G6PD</li><li>\u27a4 hexose monophosphate shunt</li><li>\u27a4 NADPH.</li><li>\u27a4 NADPH</li><li>\u27a4 reduced form of glutathione</li><li>\u27a4 antioxidant in cells.</li><li>\u27a4 G6PD deficiency,</li><li>\u27a4 NADPH</li><li>\u27a4 reduced ability to maintain glutathione</li><li>\u27a4 reduced form</li><li>\u27a4 red blood cells</li><li>\u27a4 oxidative damage</li><li>\u27a4 Ref : Harper 30/e: p 196-200.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 196-200.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "50476c39",
      "audio": ""
    },
    {
      "text": "The diagram below represents the various fates of pyruvate. Which letter on the diagram shows the reaction requiring biotin as a cofactor and is activated by acetylcoenzyme A?",
      "options": [
        {
          "label": "A",
          "text": "B",
          "correct": false
        },
        {
          "label": "B",
          "text": "C",
          "correct": true
        },
        {
          "label": "C",
          "text": "D",
          "correct": false
        },
        {
          "label": "D",
          "text": "A",
          "correct": false
        }
      ],
      "correct_answer": "B. C",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture9.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) C</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. B: Denotes PDH present in mitochondria, which oxidatively decarboxylates pyruvate to acetyl CoA.</li><li>\u2022 Option A. B:</li><li>\u2022 PDH present in mitochondria,</li><li>\u2022 oxidatively decarboxylates pyruvate to acetyl CoA.</li><li>\u2022 Option C. D: Denotes ALT. Alanine is formed by transamination of pyruvate by the enzyme alanine aminotransferase (ALT), which requires PLP.</li><li>\u2022 Option C. D:</li><li>\u2022 ALT.</li><li>\u2022 transamination of pyruvate</li><li>\u2022 alanine aminotransferase (ALT),</li><li>\u2022 PLP.</li><li>\u2022 Pyruvate + Glutamate \u2192 Alanine + alpha ketoglutarate</li><li>\u2022 Pyruvate + Glutamate \u2192 Alanine + alpha ketoglutarate</li><li>\u2022 Option D. A: Pyruvate kinase dephosphorylates phosphoenolpyruvate to pyruvate, which is a substrate level key glycolytic enzyme.</li><li>\u2022 Option D. A:</li><li>\u2022 Pyruvate kinase dephosphorylates phosphoenolpyruvate to pyruvate,</li><li>\u2022 substrate</li><li>\u2022 glycolytic enzyme.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The role of biotin is a cofactor in the carboxylation reaction catalyzed by pyruvate carboxylase and how acetyl-CoA serves as an allosteric activator of the enzyme, linking the state of cellular energy to gluconeogenesis.</li><li>\u27a4 biotin is a cofactor</li><li>\u27a4 carboxylation</li><li>\u27a4 pyruvate carboxylase</li><li>\u27a4 acetyl-CoA</li><li>\u27a4 allosteric activator</li><li>\u27a4 state of cellular energy to gluconeogenesis.</li><li>\u27a4 Ref : Harper 30/e: p 165,166.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 165,166.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3cbf6245",
      "audio": ""
    },
    {
      "text": "During a clinical review session, a medical instructor is discussing the various substrates that contribute to the production of glucose through gluconeogenesis. One of the students asks which substrates can be used by the liver to synthesize glucose. The instructor provides a list but includes one substrate that does not contribute to the net synthesis of glucose in gluconeogenesis. Which of the following does not serve as a substrate for net glucose production in gluconeogenesis?",
      "options": [
        {
          "label": "A",
          "text": "Lactate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acetyl CoA",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pyruvate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Alanine",
          "correct": false
        }
      ],
      "correct_answer": "B. Acetyl CoA",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Acetyl CoA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Lactate: Lactate can be converted to pyruvate by lactate dehydrogenase and then to glucose via gluconeogenesis.</li><li>\u2022 Option A. Lactate:</li><li>\u2022 converted to pyruvate</li><li>\u2022 lactate dehydrogenase</li><li>\u2022 glucose via gluconeogenesis.</li><li>\u2022 Option C. Pyruvate: Pyruvate is a key gluconeogenic substrate that can be carboxylated to oxaloacetate and eventually converted to glucose.</li><li>\u2022 Option C. Pyruvate:</li><li>\u2022 key gluconeogenic substrate</li><li>\u2022 carboxylated to oxaloacetate</li><li>\u2022 converted to glucose.</li><li>\u2022 Option D. Alanine: Alanine can undergo transamination to form pyruvate, which can then enter the gluconeogenesis pathway to synthesize glucose.</li><li>\u2022 Option D. Alanine:</li><li>\u2022 Alanine</li><li>\u2022 undergo transamination</li><li>\u2022 pyruvate,</li><li>\u2022 enter the gluconeogenesis</li><li>\u2022 synthesize glucose.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Substrates for Gluconeogenesis:</li><li>\u27a4 Substrates for Gluconeogenesis:</li><li>\u27a4 Glucogenic Amino Acid [Alanine is the major contributor] Lactate Glycerol Propionyl CoA.</li><li>\u27a4 Glucogenic Amino Acid [Alanine is the major contributor]</li><li>\u27a4 Glucogenic Amino Acid</li><li>\u27a4 Lactate</li><li>\u27a4 Lactate</li><li>\u27a4 Glycerol</li><li>\u27a4 Glycerol</li><li>\u27a4 Propionyl CoA.</li><li>\u27a4 Propionyl CoA.</li><li>\u27a4 Ref : Harper 30/e p185, 186.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p185, 186.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "737085b7",
      "audio": ""
    },
    {
      "text": "Which of the following examples best illustrates the concept of enzyme induction?",
      "options": [
        {
          "label": "A",
          "text": "ALA synthase by barbiturates",
          "correct": true
        },
        {
          "label": "B",
          "text": "Succinate dehydrogenase by malonate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cytochromes by cyanide",
          "correct": false
        },
        {
          "label": "D",
          "text": "ALA synthase by heme",
          "correct": false
        }
      ],
      "correct_answer": "A. ALA synthase by barbiturates",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Succinate dehydrogenase by malonate: e.g of competitive inhibition.</li><li>\u2022 Option B.</li><li>\u2022 Succinate dehydrogenase</li><li>\u2022 malonate:</li><li>\u2022 Option C. Cytochromes by cyanide : e.g of Non-competitive inhibition.</li><li>\u2022 Option C.</li><li>\u2022 Cytochromes</li><li>\u2022 cyanide</li><li>\u2022 Option D. ALA synthase by heme : e.g: of Repression.</li><li>\u2022 Option D.</li><li>\u2022 ALA synthase</li><li>\u2022 heme</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Barbiturates can induce the synthesis of ALA synthase , an enzyme involved in the heme synthesis pathway, by increasing the transcription of its gene . This is an example of enzyme induction where the presence of a compound (barbiturates) increases the production and activity of an enzyme.</li><li>\u27a4 Barbiturates</li><li>\u27a4 induce the synthesis of ALA synthase</li><li>\u27a4 enzyme</li><li>\u27a4 heme synthesis pathway,</li><li>\u27a4 increasing the transcription of its gene</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 64.</li><li>\u27a4 Ref:</li><li>\u27a4 DM Vasudevan 9/e: p 64.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1fb6d044",
      "audio": ""
    },
    {
      "text": "Among the listed enzymes, which one is NOT typically considered a non-functional enzyme?",
      "options": [
        {
          "label": "A",
          "text": "Alkaline phosphatase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acid phosphatase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lipoprotein lipase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Gamma glutamyl transpeptidase",
          "correct": false
        }
      ],
      "correct_answer": "C. Lipoprotein lipase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Lipoprotein lipase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Enzymes found in the plasma can be classified into two types:</li><li>\u2022 Non-functional (plasma marker) enzymes:</li><li>\u2022 Non-functional (plasma marker) enzymes:</li><li>\u2022 These do not perform any physiological function in plasma . Their presence in serum is typically due to cell damage or turnover . Elevated levels help identify tissue injury or disease . Examples: Alkaline phosphatase (ALP) \u2013 bone and liver disorders Acid phosphatase \u2013 prostate conditions Gamma-glutamyl transpeptidase (GGT) \u2013 hepatobiliary dysfunction LDH, CK, AST \u2013 used as diagnostic markers</li><li>\u2022 These do not perform any physiological function in plasma .</li><li>\u2022 do not perform any physiological function in plasma</li><li>\u2022 Their presence in serum is typically due to cell damage or turnover .</li><li>\u2022 cell damage or turnover</li><li>\u2022 Elevated levels help identify tissue injury or disease .</li><li>\u2022 tissue injury or disease</li><li>\u2022 Examples: Alkaline phosphatase (ALP) \u2013 bone and liver disorders Acid phosphatase \u2013 prostate conditions Gamma-glutamyl transpeptidase (GGT) \u2013 hepatobiliary dysfunction LDH, CK, AST \u2013 used as diagnostic markers</li><li>\u2022 Examples:</li><li>\u2022 Alkaline phosphatase (ALP) \u2013 bone and liver disorders Acid phosphatase \u2013 prostate conditions Gamma-glutamyl transpeptidase (GGT) \u2013 hepatobiliary dysfunction LDH, CK, AST \u2013 used as diagnostic markers</li><li>\u2022 Alkaline phosphatase (ALP) \u2013 bone and liver disorders</li><li>\u2022 Alkaline phosphatase (ALP)</li><li>\u2022 Acid phosphatase \u2013 prostate conditions</li><li>\u2022 Acid phosphatase</li><li>\u2022 Gamma-glutamyl transpeptidase (GGT) \u2013 hepatobiliary dysfunction</li><li>\u2022 Gamma-glutamyl transpeptidase (GGT)</li><li>\u2022 LDH, CK, AST \u2013 used as diagnostic markers</li><li>\u2022 LDH, CK, AST</li><li>\u2022 Functional (plasma active) enzymes:</li><li>\u2022 Functional (plasma active) enzymes:</li><li>\u2022 These perform essential metabolic functions within the circulation . They are actively secreted into plasma to carry out physiological roles .</li><li>\u2022 These perform essential metabolic functions within the circulation .</li><li>\u2022 essential metabolic functions</li><li>\u2022 within the circulation</li><li>\u2022 They are actively secreted into plasma to carry out physiological roles .</li><li>\u2022 actively secreted into plasma</li><li>\u2022 physiological roles</li><li>\u2022 Lipoprotein lipase (LPL) is a classic functional enzyme :</li><li>\u2022 Lipoprotein lipase (LPL)</li><li>\u2022 functional enzyme</li><li>\u2022 It hydrolyzes triglycerides in chylomicrons and VLDL into free fatty acids and glycerol. Plays a critical role in lipid metabolism and energy distribution .</li><li>\u2022 It hydrolyzes triglycerides in chylomicrons and VLDL into free fatty acids and glycerol.</li><li>\u2022 hydrolyzes triglycerides</li><li>\u2022 chylomicrons and VLDL</li><li>\u2022 free fatty acids</li><li>\u2022 Plays a critical role in lipid metabolism and energy distribution .</li><li>\u2022 critical role in lipid metabolism and energy distribution</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Alkaline phosphatase (ALP) \u2192 Non-functional enzyme; diagnostic marker for bone and hepatobiliary diseases . Acid phosphatase \u2192 Non-functional; historically used to detect prostate cancer . Gamma-glutamyl transpeptidase (GGT) \u2192 Non-functional; useful in assessing alcoholic liver disease and cholestasis .</li><li>\u2022 Alkaline phosphatase (ALP) \u2192 Non-functional enzyme; diagnostic marker for bone and hepatobiliary diseases .</li><li>\u2022 Alkaline phosphatase (ALP)</li><li>\u2022 bone and hepatobiliary diseases</li><li>\u2022 Acid phosphatase \u2192 Non-functional; historically used to detect prostate cancer .</li><li>\u2022 Acid phosphatase</li><li>\u2022 prostate cancer</li><li>\u2022 Gamma-glutamyl transpeptidase (GGT) \u2192 Non-functional; useful in assessing alcoholic liver disease and cholestasis .</li><li>\u2022 Gamma-glutamyl transpeptidase (GGT)</li><li>\u2022 alcoholic liver disease and cholestasis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lipoprotein lipase is a functional plasma enzyme , directly involved in lipid metabolism . In contrast, non-functional enzymes like ALP, ACP, GGT do not have roles in the plasma but serve as important clinical markers of tissue damage .</li><li>\u27a4 Lipoprotein lipase is a functional plasma enzyme , directly involved in lipid metabolism .</li><li>\u27a4 Lipoprotein lipase</li><li>\u27a4 functional plasma enzyme</li><li>\u27a4 lipid metabolism</li><li>\u27a4 In contrast, non-functional enzymes like ALP, ACP, GGT do not have roles in the plasma but serve as important clinical markers of tissue damage .</li><li>\u27a4 non-functional enzymes</li><li>\u27a4 ALP, ACP, GGT</li><li>\u27a4 not have roles in the plasma</li><li>\u27a4 clinical markers of tissue damage</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 301.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6364cb2c",
      "audio": ""
    },
    {
      "text": "During a rural health camp screening in India, a 6-year-old boy is evaluated for developmental delay and unusual skeletal features. His parents report that he has a history of frequent eye and vision issues. A genetic enzymatic defect is suspected. Which condition is associated with a defect in the enzyme cystathionine synthase?",
      "options": [
        {
          "label": "A",
          "text": "Hartnup\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cystinuria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Homocystinuria",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cystathioninuria",
          "correct": false
        }
      ],
      "correct_answer": "C. Homocystinuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hartnup\u2019s disease: Due to defective absorption of aromatic amino acids from intestine as well as reabsorption from renal tubules due to mutation of SLC6A19 gene encodes the transporter protein (B0AT1) seen in Intestine and renal tubules \u2192excretion of amino acids in urine. Due to deficiency of Tryptophan, Niacin is not produced and so, the presentation is similar to Pellagra.</li><li>\u2022 Option A. Hartnup\u2019s disease:</li><li>\u2022 defective absorption of aromatic amino acids</li><li>\u2022 Option B. Cystinuria: Due to defect/deficiency of transporter system \u2192patients cannot reabsorb cysteine into their bloodstream  \u2192 accumulation of cystine in urine forms crystals and stones \u2192 leads to recurrent nephrolithiasis and obstruction of urine flow \u2192c/f- severe, sudden flank pain, blood and WBC in urine, fever, and finally renal failure.</li><li>\u2022 Option B. Cystinuria:</li><li>\u2022 defect/deficiency of transporter system</li><li>\u2022 Option D. Cystathioninuria: Due to cystathionine deficiency , patient presents with mental retardation, anemia, thrombocytopenia and endocrinopathies. Acquired Cystathioninuria might be due to pyridoxine deficiency, liver diseases and after thyroxine administration.</li><li>\u2022 Option D. Cystathioninuria:</li><li>\u2022 cystathionine deficiency</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cystathionine synthase is an enzyme critical in the metabolism of methionine, converting homocysteine to cystathionine. A deficiency in this enzyme leads to homocystinuria, a disorder characterized by elevated levels of homocysteine, which can result in developmental delay, skeletal abnormalities, and ocular issues.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e833928",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman in India presents with fever, left flank pain radiating to the leg, and acute urinary retention. She has a similar past episode six months ago. On examination, she's tender in the abdominal region and appears anemic. Urinalysis reveals RBCs, pus cells, WBC casts, hexagonal crystals, and amino acids. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b Cystinosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cystinuria",
          "correct": true
        },
        {
          "label": "C",
          "text": "Renal Fanconi syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cystathioninuria",
          "correct": false
        }
      ],
      "correct_answer": "B. Cystinuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cystinosis: This is a lysosomal storage disorder with accumulation of excess cystine crystals in eyes and kidneys. Due to mutation in the gene CTNS, which codes for the protein cystinosin, the lysosomal cystine transporter. Symptoms: excessive urination, poor growth, photophobia and renal failure by age 6.</li><li>\u2022 Option A. Cystinosis:</li><li>\u2022 Option C. Renal Fanconi syndrome: Caused by Cystinosis with loss of large amounts of salt and other minerals in urine. It is an example of RTA Type 2, characterized by increased urinary excretion of glucose, amino acids, bicarbonate, phosphate and salt wasting.</li><li>\u2022 Option C. Renal Fanconi syndrome:</li><li>\u2022 Option D. Cystathioninuria: Due to cystathionase deficiency, presents with mental retardation, anemia, thrombocytopenia and endocrinopathies. Acquired Cystathioninuria might be due to pyridoxine deficiency, liver diseases and after thyroxine administration.</li><li>\u2022 Option D. Cystathioninuria:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of characteristic hexagonal crystals in the urine along with RBCs, pus cells, and WBC casts suggests a stone-forming condition. Cystinuria is a genetic disorder characterized by defective renal tubular reabsorption of certain amino acids including cystine, leading to the formation of cystine stones, which can manifest with urinary retention and flank pain due to obstruction.</li><li>\u27a4 Ref : Harper 30/e:  p 301-302.</li><li>\u27a4 Ref : Harper 30/e:  p 301-302.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb66459e",
      "audio": ""
    },
    {
      "text": "A 19-year-old African female presents with chronic, mild symptoms of sleeping sickness, persisting over two years. She is treated with difluoromethyl ornithine (DFMO), known for its efficacy against trypanosomiasis. DFMO inhibits the enzyme involved in polyamine synthesis, crucial for the parasite's proliferation. Based on DFMO's mechanism, what type of enzyme inhibition does it exemplify?",
      "options": [
        {
          "label": "A",
          "text": "Suicidal Inhibition",
          "correct": true
        },
        {
          "label": "B",
          "text": "Non-competitive Inhibition",
          "correct": false
        },
        {
          "label": "C",
          "text": "Uncompetitive Inhibition",
          "correct": false
        },
        {
          "label": "D",
          "text": "Allosteric Inhibition",
          "correct": false
        }
      ],
      "correct_answer": "A. Suicidal Inhibition",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Non-competitive: Cyanide inhibits cytochrome oxidase, Fluoride inhibit enolase thereby consequently the glycolysis, Iodoacetate inhibit enzymes having \u2013SH group in their active centers, BAL (dimercaprol) as an antidote for heavy metal poisoning etc.</li><li>\u2022 Option B. Non-competitive:</li><li>\u2022 Cyanide</li><li>\u2022 cytochrome oxidase,</li><li>\u2022 Option C. Uncompetitive: Inhibition of placental alkaline phosphatase (Regan iso-enzyme) by phenylalanine.</li><li>\u2022 Option C. Uncompetitive:</li><li>\u2022 phenylalanine.</li><li>\u2022 Option D. Allosteric: ALA Synthase catalyse the first step in heme biosynthesis and the end product, heme will allosterically inhibit the enzyme.</li><li>\u2022 Option D. Allosteric:</li><li>\u2022 ALA Synthase catalyse</li><li>\u2022 heme biosynthesis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 DFMO acts as a suicidal (or suicide) inhibitor by irreversibly binding to and inactivating ornithine decarboxylase , the enzyme responsible for polyamine synthesis essential for the growth and reproduction of Trypanosoma brucei, the parasite causing sleeping sickness . Suicidal inhibitors form a covalent bond with the enzyme, leading to its permanent inactivation.</li><li>\u27a4 DFMO acts as a suicidal</li><li>\u27a4 inhibitor</li><li>\u27a4 irreversibly binding to and inactivating ornithine decarboxylase</li><li>\u27a4 enzyme</li><li>\u27a4 polyamine synthesis</li><li>\u27a4 growth and reproduction of Trypanosoma brucei,</li><li>\u27a4 parasite</li><li>\u27a4 sleeping sickness</li><li>\u27a4 Ref: Harper 30/e p78.</li><li>\u27a4 Ref:</li><li>\u27a4 Harper 30/e p78.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ccc87378",
      "audio": ""
    },
    {
      "text": "A 7-year-old girl presents with progressive involuntary movements in her right hand and visual difficulties noted over the past year. Blood work reveals elevated serum homocysteine with normal liver, renal, thyroid function tests, and electrolytes. She responds favorably to high-dose pyridoxine and a methionine-restricted diet, with a noted improvement in dystonic movements after three months. What condition is most likely affecting this child?",
      "options": [
        {
          "label": "A",
          "text": "Hartnup\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cystinuria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Classical Homocystinuria",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cystathioninuria",
          "correct": false
        }
      ],
      "correct_answer": "C. Classical Homocystinuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hartnup\u2019s disease: Due to defective absorption of aromatic amino acids from intestine as well as reabsorption from renal tubules \u2192excretion of amino acids in urine.</li><li>\u2022 Option A. Hartnup\u2019s disease:</li><li>\u2022 defective absorption of aromatic amino acids</li><li>\u2022 intestine</li><li>\u2022 reabsorption from renal tubules</li><li>\u2022 Option B. Cystinuria: Due to defect/deficiency of transporter system \u2192patients cannot reabsorb cysteine into their bloodstream \u2192accumulation of cystine in urine forms stones \u2192leads to recurrent nephrolithiasis, obstruction, and finally renal failure.</li><li>\u2022 Option B. Cystinuria:</li><li>\u2022 defect/deficiency of transporter system</li><li>\u2022 bloodstream</li><li>\u2022 Option D. Cystathioninuria: Due to cystathionase deficiency , patient presents with mental retardation, anemia, thrombocytopenia and endocrinopathies.</li><li>\u2022 Option D. Cystathioninuria:</li><li>\u2022 cystathionase deficiency</li><li>\u2022 mental retardation, anemia, thrombocytopenia</li><li>\u2022 endocrinopathies.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Classical homocystinuria is often due to a deficiency in the enzyme cystathionine \u03b2-synthase, leading to elevated homocysteine levels . Treatment with high-dose pyridoxine (vitamin B6), a cofactor for the enzyme , can improve symptoms , and a methionine-restricted diet can help manage homocysteine levels . The improvement in dystonia with treatment supports this diagnosis.</li><li>\u27a4 Classical homocystinuria</li><li>\u27a4 deficiency in the enzyme cystathionine \u03b2-synthase,</li><li>\u27a4 elevated homocysteine levels</li><li>\u27a4 high-dose pyridoxine</li><li>\u27a4 cofactor for the enzyme</li><li>\u27a4 improve symptoms</li><li>\u27a4 methionine-restricted diet</li><li>\u27a4 manage homocysteine levels</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e88a8a32",
      "audio": ""
    },
    {
      "text": "Match the following metabolic disorders with their corresponding enzyme defect or deficiency:",
      "options": [
        {
          "label": "A",
          "text": "1-a, 2-b, 3-c, 4-d",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-b, 2-a, 3-d, 4-c",
          "correct": true
        },
        {
          "label": "C",
          "text": "1-d, 2-c, 3-b, 4-a",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-c, 2-b, 3-a, 4-d",
          "correct": false
        }
      ],
      "correct_answer": "B. 1-b, 2-a, 3-d, 4-c",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-173851.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-104916.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-175323.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 211, 221.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 211, 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0643981e",
      "audio": ""
    },
    {
      "text": "Which group among the following is responsible for buffering activity of proteins at physiological pH?",
      "options": [
        {
          "label": "A",
          "text": "Sulfhydryl group",
          "correct": false
        },
        {
          "label": "B",
          "text": "Indole group",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phenyl group",
          "correct": false
        },
        {
          "label": "D",
          "text": "Imidazole group",
          "correct": true
        }
      ],
      "correct_answer": "D. Imidazole group",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture28.jpg"
      ],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Only amino acid whose pKa value (6.1) is nearby physiological pH (7.4) is Histidine ( Imidazole group ), due to which it has buffering activity at physiological pH.</li><li>\u27a4 amino acid</li><li>\u27a4 pKa value (6.1)</li><li>\u27a4 physiological pH (7.4)</li><li>\u27a4 Histidine</li><li>\u27a4 Imidazole group</li><li>\u27a4 buffering</li><li>\u27a4 activity</li><li>\u27a4 physiological pH.</li><li>\u27a4 Ref : Vasudevan 9/e: p 28.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: p 28.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e2a9c5b2",
      "audio": ""
    },
    {
      "text": "During a biochemistry tutorial, the discussion focuses on the various levels of protein structure and the types of bonds that stabilize each level. A key topic is the primary structure of proteins and the specific type of bond that links amino acids together in a polypeptide chain. Which type of bond is involved in the formation of the primary structure of a protein or polypeptide?",
      "options": [
        {
          "label": "A",
          "text": "Covalent",
          "correct": false
        },
        {
          "label": "B",
          "text": "Peptide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amide Bond",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture2.jpg"
      ],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "51cb45bf",
      "audio": ""
    },
    {
      "text": "A 28-year-old marathon runner visits a sports medicine clinic complaining of prolonged recovery times after long training sessions. She's interested in optimizing her nutrition to enhance muscle repair and overall performance. Her recent blood work showed slightly elevated homocysteine levels. The physician decides to focus on her dietary intake, specifically the vitamins involved in the metabolism of sulfur-containing amino acids, which are crucial for muscle recovery. Which vitamins should the physician consider crucial in this metabolic pathway to address the runner's concerns and blood work findings?",
      "options": [
        {
          "label": "A",
          "text": "Vitamin B 12",
          "correct": false
        },
        {
          "label": "B",
          "text": "Folic acid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vitamin K",
          "correct": false
        },
        {
          "label": "D",
          "text": "Both a and b",
          "correct": true
        }
      ],
      "correct_answer": "D. Both a and b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Both a and b</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vitamin B12 and folic acid play pivotal roles in the metabolism of sulfur-containing amino acids . Vitamin B12 is involved in the conversion of homocysteine to methionine, while folic acid is essential for the remethylation of homocysteine , also contributing to its conversion back to methionine . These processes are crucial for maintaining low levels of homocysteine, high levels of which are associated with cardiovascular diseases.</li><li>\u27a4 Vitamin B12</li><li>\u27a4 folic acid</li><li>\u27a4 pivotal roles in the metabolism of sulfur-containing amino acids</li><li>\u27a4 Vitamin B12</li><li>\u27a4 conversion of homocysteine to methionine,</li><li>\u27a4 folic acid</li><li>\u27a4 remethylation of homocysteine</li><li>\u27a4 conversion back to methionine</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 216.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 216.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3ea81287",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with progressive palmoplantar, nose & pinna pigmentation. Urine sample collected for benedict's test changes to black in the supernatant and the test gives greenish brown precipitate. What is the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Phenylketonuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alkaptonuria",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tyrosinemia type 2",
          "correct": false
        },
        {
          "label": "D",
          "text": "Argininosuccinic aciduria",
          "correct": false
        }
      ],
      "correct_answer": "B. Alkaptonuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Phenylketonuria: Deficiency of phenylalanine hydroxylase ; C/F - mentally retardation, agitation, hyperactivity, tremors & convulsions due to interference of phenylalanine with neurotransmitter synthesis & hypopigmentation (inhibition of tyrosinase)</li><li>\u2022 Option A. Phenylketonuria:</li><li>\u2022 Deficiency</li><li>\u2022 phenylalanine hydroxylase</li><li>\u2022 Option C. Tyrosinemia type-2: Deficiency of tyrosine transaminase ; C/F -Mental retardation, painful corneal lesions, photophobia and keratosis of palmar surface with increased urinary excretion of tyrosine and tyramine.</li><li>\u2022 Option C. Tyrosinemia type-2:</li><li>\u2022 Deficiency</li><li>\u2022 tyrosine transaminase</li><li>\u2022 Option D. Argininosuccinic aciduria: Deficiency of argininosuccinate lyase with hyperammonemia and elevated argininosuccinate in CSF and excretion in urine and friable tufted hair (trichorrhexis nodosa).</li><li>\u2022 Option D. Argininosuccinic aciduria:</li><li>\u2022 Deficiency</li><li>\u2022 argininosuccinate lyase</li><li>\u2022 hyperammonemia</li><li>\u2022 elevated argininosuccinate</li><li>\u2022 CSF</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alkaptonuria is a rare metabolic disorder characterized by the accumulation of homogentisic acid , leading to its oxidation and polymerization, particularly in connective tissues (a condition known as ochronosis), resulting in dark pigmentation . The urine turning black upon standing or after adding an alkalizing agent (in this case, noted during a Benedict's test) is a hallmark sign of this condition.</li><li>\u27a4 Alkaptonuria</li><li>\u27a4 rare metabolic disorder</li><li>\u27a4 accumulation of homogentisic acid</li><li>\u27a4 oxidation</li><li>\u27a4 polymerization,</li><li>\u27a4 connective tissues</li><li>\u27a4 dark pigmentation</li><li>\u27a4 Ref : Harper 30/e: p 304-305, Lippincott 7/e: P 274.</li><li>\u27a4 Ref : Harper 30/e: p 304-305, Lippincott 7/e: P 274.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbc40033",
      "audio": ""
    },
    {
      "text": "Which of the following enzymes fits the definition of a lyase?",
      "options": [
        {
          "label": "A",
          "text": "Aldolase B",
          "correct": true
        },
        {
          "label": "B",
          "text": "Lactate dehydrogenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acetylcholine Esterase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acetyl CoA carboxylase",
          "correct": false
        }
      ],
      "correct_answer": "A. Aldolase B",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Lactate dehydrogenase: This enzyme is classified as an oxidoreductase. It catalyzes the interconversion of pyruvate and lactate with concomitant interconversion of NADH and NAD+.</li><li>\u2022 Option B. Lactate dehydrogenase:</li><li>\u2022 classified as an oxidoreductase.</li><li>\u2022 Option C. Acetylcholine esterase: This enzyme is a hydrolase, not a lyase. It catalyzes the hydrolysis of acetylcholine into choline and acetate, a critical reaction in the function of the nervous system.</li><li>\u2022 Option C. Acetylcholine esterase:</li><li>\u2022 enzyme is a hydrolase,</li><li>\u2022 Option D. Acetyl CoA carboxylase: This enzyme is a ligase (more specifically, a biotin-dependent carboxylase). It catalyzes the ATP-dependent carboxylation of acetyl-CoA to produce malonyl-CoA, a key step in fatty acid synthesis.</li><li>\u2022 Option D. Acetyl CoA carboxylase:</li><li>\u2022 enzyme is a ligase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Some examples of Lyases are:</li><li>\u27a4 Lyases</li><li>\u27a4 HMG CoA Lyase Argininosuccinate Lyase ATP Citrate Lyase Aldolase Fumarase</li><li>\u27a4 HMG CoA Lyase</li><li>\u27a4 Argininosuccinate Lyase</li><li>\u27a4 ATP Citrate Lyase</li><li>\u27a4 Aldolase</li><li>\u27a4 Fumarase</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 49.</li><li>\u27a4 Ref:</li><li>\u27a4 DM Vasudevan 9/e: p 49.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1655604d",
      "audio": ""
    },
    {
      "text": "A concerned mother brings her 2-month-old infant to the pediatric clinic, reporting that the baby's urine has a distinct cabbage-like odor. This unusual symptom prompts the pediatrician to consider metabolic disorders that could be associated with such an olfactory finding. Based on the described symptom, what is the most probable diagnosis for this infant?",
      "options": [
        {
          "label": "A",
          "text": "Leucine catabolism defect",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hawkinsinuria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosinemia type 1",
          "correct": true
        },
        {
          "label": "D",
          "text": "Maple syrup urine disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Tyrosinemia type 1",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/screenshot-2024-04-04-100432.jpg"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Leucine catabolism defect: Incorrect, as defects in leucine metabolism typically lead to the odor of maple syrup in the urine, not cabbage.</li><li>\u2022 Option</li><li>\u2022 A. Leucine catabolism defect:</li><li>\u2022 defects in leucine metabolism</li><li>\u2022 Option B. Hawkinsinuria: Incorrect, as this very rare metabolic disorder does not typically present with cabbage odor urine.</li><li>\u2022 Option</li><li>\u2022 B. Hawkinsinuria:</li><li>\u2022 very rare metabolic disorder</li><li>\u2022 Option D. Maple syrup urine disease: Incorrect, as the characteristic odor associated with this disorder is sweet or burnt sugar , resembling maple syrup, not cabbage.</li><li>\u2022 Option</li><li>\u2022 D. Maple syrup urine disease:</li><li>\u2022 odor</li><li>\u2022 disorder is sweet or burnt sugar</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Harper 30/e: p 304-307, DM Vasudevan  9/e: p 239,240</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 304-307, DM Vasudevan  9/e: p 239,240</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e055de76",
      "audio": ""
    },
    {
      "text": "One specialized organ in mammals has a unique adaptation that allows it to utilize fuel oxidation not primarily for ATP production but for the generation of heat, aiding in thermoregulation. Which of the following is this specialized organ?",
      "options": [
        {
          "label": "A",
          "text": "Adrenal gland",
          "correct": false
        },
        {
          "label": "B",
          "text": "Skeletal music",
          "correct": false
        },
        {
          "label": "C",
          "text": "Brown adipose tissue",
          "correct": true
        },
        {
          "label": "D",
          "text": "Heart",
          "correct": false
        }
      ],
      "correct_answer": "C. Brown adipose tissue",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Brown adipose tissue</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Brown adipose tissue is the specialized organ in mammals designed for heat production through non-shivering thermogenesis, emphasizing its role in thermoregulation and energy metabolism.</li><li>\u27a4 Brown adipose tissue</li><li>\u27a4 mammals designed</li><li>\u27a4 heat production</li><li>\u27a4 non-shivering thermogenesis,</li><li>\u27a4 thermoregulation and energy metabolism.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 162, 267.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 162, 267.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dfc11cec",
      "audio": ""
    },
    {
      "text": "How should the following inhibitors be matched with their corresponding complexes or sites?",
      "options": [
        {
          "label": "A",
          "text": "1-d, 2-c, 3-b, 4-a",
          "correct": true
        },
        {
          "label": "B",
          "text": "1-d, 2-b, 3-c, 4-a",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-a, 2-b, 3-c, 4-d",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-a, 2-d, 3-b, 4-c",
          "correct": false
        }
      ],
      "correct_answer": "A. 1-d, 2-c, 3-b, 4-a",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture4_784r4vb.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture5.jpg"
      ],
      "explanation": "<p><strong>Ans. A) 1-d, 2-c, 3-b, 4-a</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Cyanide is known to inhibit Complex IV of the electron transport chain by binding to the cytochrome c oxidase , preventing the transfer of electrons to oxygen and thereby halting ATP synthesis. Malonate is a competitive inhibitor of succinate dehydrogenase (Complex II), specifically inhibiting the site between succinate dehydrogenase and Co-Q (coenzyme Q). BAL (British Anti-Lewisite) does not directly inhibit any specific complex within the electron transport chain; thus, its inclusion might be misleading . However, in the context of this question and the available options, it is matched with b, but this is not reflective of its actual function. Chlorpromazine is not a classical inhibitor of the electron transport chain , and its inclusion in this list might not be accurate for educational purposes . However, based on the available options, it is matched with a, Complex I to Co-Q.</li><li>\u2022 Cyanide is known to inhibit Complex IV of the electron transport chain by binding to the cytochrome c oxidase , preventing the transfer of electrons to oxygen and thereby halting ATP synthesis.</li><li>\u2022 Cyanide</li><li>\u2022 inhibit Complex IV</li><li>\u2022 cytochrome c oxidase</li><li>\u2022 preventing</li><li>\u2022 electrons to oxygen</li><li>\u2022 halting ATP synthesis.</li><li>\u2022 Malonate is a competitive inhibitor of succinate dehydrogenase (Complex II), specifically inhibiting the site between succinate dehydrogenase and Co-Q (coenzyme Q).</li><li>\u2022 Malonate</li><li>\u2022 competitive</li><li>\u2022 succinate dehydrogenase (Complex II),</li><li>\u2022 inhibiting</li><li>\u2022 succinate dehydrogenase and Co-Q (coenzyme Q).</li><li>\u2022 BAL (British Anti-Lewisite) does not directly inhibit any specific complex within the electron transport chain; thus, its inclusion might be misleading . However, in the context of this question and the available options, it is matched with b, but this is not reflective of its actual function.</li><li>\u2022 BAL (British Anti-Lewisite) does not</li><li>\u2022 inhibit</li><li>\u2022 complex</li><li>\u2022 electron transport chain;</li><li>\u2022 inclusion</li><li>\u2022 misleading</li><li>\u2022 it is matched with b,</li><li>\u2022 not reflective</li><li>\u2022 actual function.</li><li>\u2022 Chlorpromazine is not a classical inhibitor of the electron transport chain , and its inclusion in this list might not be accurate for educational purposes . However, based on the available options, it is matched with a, Complex I to Co-Q.</li><li>\u2022 Chlorpromazine</li><li>\u2022 not</li><li>\u2022 classical inhibitor</li><li>\u2022 electron transport chain</li><li>\u2022 might not</li><li>\u2022 educational purposes</li><li>\u2022 matched with a, Complex I to Co-Q.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 266.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 266.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d6b11997",
      "audio": ""
    },
    {
      "text": "A pediatrician is evaluating a newborn for potential metabolic disorders due to some concerning symptoms. Given the suspicion of phenylketonuria (PKU) among other metabolic conditions, the pediatrician considers the most effective screening method to identify such diseases in their early stages. Which screening test is considered the gold standard for detecting PKU and similar metabolic disorders in newborns?",
      "options": [
        {
          "label": "A",
          "text": "Western blot",
          "correct": false
        },
        {
          "label": "B",
          "text": "Electrophoresis",
          "correct": false
        },
        {
          "label": "C",
          "text": "FISH",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tandem Mass spectrometry",
          "correct": true
        }
      ],
      "correct_answer": "D. Tandem Mass spectrometry",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Western blot: Incorrect, as it's primarily used for protein analysis and not typically for newborn metabolic screening.</li><li>\u2022 Option</li><li>\u2022 A. Western blot:</li><li>\u2022 Option B. Electrophoresis: Incorrect, while it can separate molecules based on size and charge, it's not as comprehensive or specific for metabolic disorders as tandem mass spectrometry.</li><li>\u2022 Option B. Electrophoresis:</li><li>\u2022 Option C. FISH (Fluorescence In Situ Hybridization): Incorrect, as FISH is mainly used for detecting chromosomal abnormalities and gene mapping, not for screening metabolic disorders like PKU.</li><li>\u2022 Option</li><li>\u2022 C. FISH (Fluorescence In Situ Hybridization):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tandem Mass Spectrometry (MS/MS) is widely used in newborn screening programs for the detection of various metabolic disorders, including phenylketonuria (PKU). This method allows for the simultaneous screening of multiple disorders by analyzing patterns of specific metabolites in a small blood sample, usually obtained via heel prick in newborns. Its sensitivity and specificity make it an ideal choice for early detection.</li><li>\u27a4 Ref : DM Vasudevan 9/e :p 427</li><li>\u27a4 Ref : DM Vasudevan 9/e :p 427</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c3d13386",
      "audio": ""
    },
    {
      "text": "A 54-year-old woman presents to the outpatient department with a constellation of symptoms including flushing, a non-healing ulcer, diarrhea, and episodes of bronchospasm. Laboratory investigations reveal elevated levels of 5-Hydroxyindoleacetic Acid (5-HIAA) in her blood. Based on these findings, what is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Glucagonoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gastrinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carcinoid syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Insulinoma",
          "correct": false
        }
      ],
      "correct_answer": "C. Carcinoid syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A Glucagonoma: Is a rare tumour of pancreatic alpha cells , resulting in overproduction of glucagon . It is associated with necrolytic migratory erythema, weight loss and diabetes mellitus.</li><li>\u2022 Option A Glucagonoma:</li><li>\u2022 rare tumour of pancreatic alpha cells</li><li>\u2022 overproduction of glucagon</li><li>\u2022 Option B. Gastrinoma: Is a gastrin secreting tumour of pancreas resulting in Zollinger-Ellison syndrome , where there is no feedback regulation of gastrin secretion causing very high level of gastric acid output along with high serum gastrin levels.</li><li>\u2022 Option B. Gastrinoma:</li><li>\u2022 gastrin secreting tumour</li><li>\u2022 pancreas</li><li>\u2022 Zollinger-Ellison syndrome</li><li>\u2022 Option D. Insulinoma: Is an Insulin secreting tumours characterized by constant high production of insulin (C-peptide) and decreased blood glucose by the tumour cells.</li><li>\u2022 Option D. Insulinoma:</li><li>\u2022 Insulin secreting tumours</li><li>\u2022 constant high production of insulin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Carcinoid syndrome is characterized by a set of symptoms that include flushing, diarrhea, bronchospasm , and, in some cases, heart valve lesions . These symptoms are caused by the overproduction of serotonin by carcinoid tumors , most commonly originating in the gastrointestinal tract or lungs . Elevated levels of 5-Hydroxyindoleacetic Acid (5-HIAA), a metabolite of serotonin , in the urine or blood are a hallmark finding in carcinoid syndrome and support this diagnosis.</li><li>\u27a4 Carcinoid syndrome</li><li>\u27a4 set of symptoms</li><li>\u27a4 flushing, diarrhea, bronchospasm</li><li>\u27a4 heart valve lesions</li><li>\u27a4 overproduction of serotonin by carcinoid tumors</li><li>\u27a4 originating in the gastrointestinal tract or lungs</li><li>\u27a4 Elevated levels of 5-Hydroxyindoleacetic Acid</li><li>\u27a4 metabolite of serotonin</li><li>\u27a4 urine</li><li>\u27a4 blood</li><li>\u27a4 carcinoid syndrome</li><li>\u27a4 Ref : Harper 30/e: pg 557, DM Vasudevan  9/e: p 241-242</li><li>\u27a4 Ref : Harper 30/e: pg 557, DM Vasudevan  9/e: p 241-242</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7e1d6bc",
      "audio": ""
    },
    {
      "text": "During a routine neonatal examination, a newborn girl is noted to have blue eyes, blond hair, and fair skin. A Guthrie test is performed, yielding positive results. Among the following statements related to this case, which one is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Due to deficiency of enzyme Phenylalanine Hydroxylase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mental retardation is a potential complication",
          "correct": false
        },
        {
          "label": "C",
          "text": "Presence of a white patch of hair is due to a deficiency in tryptophan",
          "correct": true
        },
        {
          "label": "D",
          "text": "Phenylacetate is found in the urine",
          "correct": false
        }
      ],
      "correct_answer": "C. Presence of a white patch of hair is due to a deficiency in tryptophan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Presence of a white patch of hair is due to a deficiency in tryptophan</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Phenylketonuria results from phenylalanine hydroxylase deficiency, causing elevated phenylalanine levels and reduced tyrosine. The hypopigmentation seen in PKU patients is due to impaired melanin synthesis from reduced tyrosine availability\u2014not from tryptophan deficiency. Early detection through newborn screening and prompt dietary management are essential to prevent the neurological sequelae of this inborn error of metabolism.</li><li>\u27a4 Ref : Harper 30/e:  p 304-306</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "64b529a8",
      "audio": ""
    },
    {
      "text": "A 2-year-old child is brought to the clinic with symptoms resembling pellagra, including dermatitis, ataxia, and neuropsychiatric manifestations. Urine analysis indicates aminoaciduria. Considering the presentation and the urinary findings, this disorder is likely due to a mutation in which of the following genes?",
      "options": [
        {
          "label": "A",
          "text": "SLC5A18",
          "correct": false
        },
        {
          "label": "B",
          "text": "SLC1A1",
          "correct": false
        },
        {
          "label": "C",
          "text": "SLC7A9",
          "correct": false
        },
        {
          "label": "D",
          "text": "SLC6A19",
          "correct": true
        }
      ],
      "correct_answer": "D. SLC6A19",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. SLC5A18: This gene is not associated with the described clinical presentation or aminoaciduria related to Hartnup disease.</li><li>\u2022 Option</li><li>\u2022 A. SLC5A18:</li><li>\u2022 not associated</li><li>\u2022 Option B. SLC1A1: While this gene is involved in amino acid transport, mutations in SLC1A1 are not typically linked to the symptoms described here.</li><li>\u2022 Option</li><li>\u2022 B. SLC1A1:</li><li>\u2022 amino acid transport,</li><li>\u2022 Option C. SLC7A9: Mutations in this gene are associated with cystinuria, a different condition characterized by defective renal reabsorption of certain amino acids, leading to kidney stone formation, not the symptoms described.</li><li>\u2022 Option</li><li>\u2022 C. SLC7A9:</li><li>\u2022 Mutations</li><li>\u2022 cystinuria,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 P ellagra-like symptoms (dermatitis, diarrhea, dementia), along with aminoaciduria , suggests Hartnup disease , which is characterized by the defective absorption of neutral amino acids, including tryptophan. Hartnup disease is caused by mutations in the SLC6A19 gene, which encodes a transporter protein responsible for the absorption of neutral amino acids in the intestines and kidneys.</li><li>\u27a4 P</li><li>\u27a4 ellagra-like symptoms</li><li>\u27a4 aminoaciduria</li><li>\u27a4 Hartnup disease</li><li>\u27a4 defective absorption of neutral amino acids,</li><li>\u27a4 tryptophan.</li><li>\u27a4 Ref : Harper 30/e:  p 308, 557</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 308, 557</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abb9b01a",
      "audio": ""
    },
    {
      "text": "A 10-year-old girl presents with a history of mild mental retardation, episodes of vomiting, lethargy, seizures, and hypertonia that were first noted during the initial week of life. Amino acid screening reveals elevated levels of leucine, isoleucine, and valine. Based on these findings, which enzyme is likely deficient in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Branched chain ketoacid dehydrogenase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cystathionine synthase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ornithine transcarbamylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methyl malonyl CoA mutase",
          "correct": false
        }
      ],
      "correct_answer": "A. Branched chain ketoacid dehydrogenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Cystathionine synthase: Congenital homocystinuria , C/F-Mental retardation, Ectopia lentis, Thrombosis and Charlie Chaplin gait.</li><li>\u2022 Option B. Cystathionine synthase:</li><li>\u2022 Congenital homocystinuria</li><li>\u2022 Option C. Ornithine transcarbamylase: The only urea cycle disorder with X-linked trait. C/F- Hyperammonaemia, elevated levels of ammonia are associated with high glutamine levels in CSF and blood in the affected child. Mothers also have hyperammonaemia and an aversion to high protein diet.</li><li>\u2022 Option C. Ornithine transcarbamylase:</li><li>\u2022 urea cycle disorder</li><li>\u2022 X-linked trait.</li><li>\u2022 Option D. Methylmalonyl CoA mutase: Methylmalonic Aciduria . C/F- MR, ketosis, hypotonia, Blood-methyl malonic acid is elevated and in urine -methyl maIonic acid and ketone bodies are seen. Treatment \u2013Vitamin B12.</li><li>\u2022 Option D. Methylmalonyl CoA mutase:</li><li>\u2022 Methylmalonic Aciduria</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The elevated levels of leucine , isoleucine , and valine indicate Maple Syrup Urine Disease (MSUD), which is caused by a deficiency in the branched chain ketoacid dehydrogenase complex.</li><li>\u27a4 elevated levels of leucine</li><li>\u27a4 isoleucine</li><li>\u27a4 valine</li><li>\u27a4 Maple Syrup Urine Disease</li><li>\u27a4 deficiency in the branched chain ketoacid dehydrogenase complex.</li><li>\u27a4 Ref : Harper 30/e:  p 309-311.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 309-311.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4f75a463",
      "audio": ""
    },
    {
      "text": "During a case discussion, involving altered immune and neurological functions, focusing on a specific metabolic pathway. The students are asked to identify the precursor amino acid in the kynurenine pathway, known to impact both neurological and immune responses. Which amino acid is focus of this discussion?",
      "options": [
        {
          "label": "A",
          "text": "Phenylalanine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tryptophan",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tyrosine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Histidine",
          "correct": false
        }
      ],
      "correct_answer": "B. Tryptophan",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture21.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Phenylalanine: This amino acid is primarily converted into tyrosine , not kynurenine.</li><li>\u2022 Option</li><li>\u2022 A. Phenylalanine:</li><li>\u2022 amino acid</li><li>\u2022 converted into tyrosine</li><li>\u2022 Option C. Tyrosine: Tyrosine is a precursor for several important substances, including dopamine, epinephrine , and norepinephrine, but not kynurenine.</li><li>\u2022 Option</li><li>\u2022 C. Tyrosine:</li><li>\u2022 substances,</li><li>\u2022 dopamine, epinephrine</li><li>\u2022 norepinephrine,</li><li>\u2022 Option D. Histidine: Histidine is metabolized into histamine, among other products, and does not lead to kynurenine formation.</li><li>\u2022 Option</li><li>\u2022 D. Histidine:</li><li>\u2022 metabolized into histamine,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Kynurenine is formed from the catabolism of tryptophan via the kynurenine pathway . This pathway is crucial not only for the degradation of tryptophan but also for the production of several important metabolites, including nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cellular energy metabolism and cellular signaling processes.</li><li>\u27a4 Kynurenine</li><li>\u27a4 formed from the catabolism</li><li>\u27a4 tryptophan</li><li>\u27a4 kynurenine pathway</li><li>\u27a4 pathway</li><li>\u27a4 degradation of tryptophan</li><li>\u27a4 production of several important metabolites,</li><li>\u27a4 nicotinamide adenine</li><li>\u27a4 dinucleotide</li><li>\u27a4 vital role in cellular energy metabolism</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 240.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6b9af3cf",
      "audio": ""
    },
    {
      "text": "Which of the following diseases is least likely to include neurological symptoms in its classic presentation?",
      "options": [
        {
          "label": "A",
          "text": "Tay-Sachs disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Niemann-Pick disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gaucher\u2019s disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "GM 1 gangliosidoses",
          "correct": false
        }
      ],
      "correct_answer": "C. Gaucher\u2019s disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)\u00a0Gaucher\u2019s disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A: Tay-Sachs disease : C/F: Neurological Symptoms, Mental retardation. Cherry red spot in the macula. Progressive deterioration No Hepatosplenomegaly.</li><li>\u2022 Option A: Tay-Sachs disease</li><li>\u2022 Option B: Niemann-Pick disease : C/F:  Severe CNS damage, mental retardation, hepatosplenomegaly, Cherry red spot in macula.</li><li>\u2022 Option B: Niemann-Pick disease</li><li>\u2022 Option D: GM1 gangliosidoses : C/F: Mental retardation, hepatomegaly, skeletal deformities. Angiokeratoma. Cherry red spot in the retina.</li><li>\u2022 Option D: GM1 gangliosidoses</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gaucher's disease, particularly type 1, which is the most common form, does not usually present with neurological symptoms. This type is known as non-neuronopathic and primarily affects the spleen, liver, and bones.</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 260, 261.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abe774e4",
      "audio": ""
    },
    {
      "text": "A pediatrician evaluating a 6-month-old girl brought in by her mother. The baby has a history of repeated infections, fever, vomiting, and one seizure episode. There's a significant family history: an elder brother passed away at 3 years old from an undiagnosed condition. The baby appears lethargic and hypotonic, with bilateral nystagmus and a cherry red spot visible in both eyes. A blood examination reveals a decreased level of Hexosaminidase A enzyme, prompting the pediatrician to consider a genetic metabolic disorder. What is the most probable diagnosis for this baby?",
      "options": [
        {
          "label": "A",
          "text": "Gaucher\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Niemann Pick disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tay-Sachs disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sandhoff's disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Tay-Sachs disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_8cdDTT6.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Tay-Sachs disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A: Gaucher\u2019s disease type 1 : Due to deficiency of beta-glucocerebrosidase, C/F: Enlarged liver and spleen, erosion of long bones, no mental retardation, no cherry red spot</li><li>\u2022 Option A: Gaucher\u2019s disease type 1</li><li>\u2022 Option B: Niemann Pick disease : Due to deficiency of Sphingomyelinase. C/F: Mental retardation, blindness, muscular weakness, hepatosplenomegaly with Cherry red spot in macula. Death by 2 years of age.</li><li>\u2022 Option B: Niemann Pick disease</li><li>\u2022 Option D: Sandhoff\u2019s disease : Due to deficiency of Hexosaminidase A and B, c/f: Neurological deficit and MR with cherry red spot.</li><li>\u2022 Option D: Sandhoff\u2019s disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tay-Sachs disease is a genetic disorder characterized by the absence or insufficient activity of an enzyme called Hexosaminidase A, leading to the accumulation of GM2 ganglioside within lysosomes, causing progressive neurological damage.</li><li>\u27a4 Ref: Harper 30/e: p 68,251.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3eb43172",
      "audio": ""
    },
    {
      "text": "While studying the regulation of metabolic pathways, a medical student comes across the concept of allosteric control, particularly its role in enzyme activity. Allosteric enzymes have unique characteristics that differentiate them from other enzymes. Which of the following statements accurately describes a property of allosteric enzymes?",
      "options": [
        {
          "label": "A",
          "text": "Allosteric effectors bind allosteric enzymes at their active sites",
          "correct": false
        },
        {
          "label": "B",
          "text": "Allosteric enzymes possess secondary structure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Allosteric control is irreversible",
          "correct": false
        },
        {
          "label": "D",
          "text": "Allosteric control with negative feedback is found in many metabolic pathways",
          "correct": true
        }
      ],
      "correct_answer": "D. Allosteric control with negative feedback is found in many metabolic pathways",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-160837.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Allosteric control with negative feedback is found in many metabolic pathways</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Allosteric control with negative feedback is indeed a key regulatory mechanism in many metabolic pathways, making option D correct. In negative feedback allosteric regulation, the end product of a metabolic pathway inhibits an enzyme at an earlier step in the pathway, effectively shutting down production when sufficient product has accumulated. Classic examples include:</li><li>\u2022 Inhibition of phosphofructokinase-1 (PFK-1) by ATP in glycolysis Inhibition of aspartate transcarbamoylase (ATCase) by CTP in pyrimidine synthesis</li><li>\u2022 Inhibition of phosphofructokinase-1 (PFK-1) by ATP in glycolysis</li><li>\u2022 Inhibition of aspartate transcarbamoylase (ATCase) by CTP in pyrimidine synthesis</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A. Allosteric effectors bind allosteric enzymes at their active sites : This statement is incorrect. By definition, allosteric effectors bind to sites distinct from the active site, called allosteric sites. The term \"allosteric\" comes from \"allo\" (other) and \"steric\" (space or structure), referring to binding at a site other than the active site. When an allosteric effector binds, it induces a conformational change that alters the activity of the enzyme.</li><li>\u2022 Option A. Allosteric effectors bind allosteric enzymes at their active sites</li><li>\u2022 Option B. Allosteric enzymes possess secondary structure : This statement is correct but not distinctive. All proteins, including enzymes (allosteric or not), possess secondary structure elements such as alpha helices and beta sheets. This is not a unique characteristic of allosteric enzymes.</li><li>\u2022 Option B. Allosteric enzymes possess secondary structure</li><li>\u2022 Option C. Allosteric control is irreversible : This is incorrect. Allosteric regulation is typically reversible, allowing for rapid adaptation to changing cellular conditions. When the concentration of the allosteric effector decreases, the enzyme can return to its original conformation and activity state.</li><li>\u2022 Option C. Allosteric control is irreversible</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Allosteric enzymes are typically oligomeric proteins with multiple subunits that exhibit cooperativity and sigmoidal kinetics rather than the hyperbolic kinetics of Michaelis-Menten enzymes. Their activity can be modulated by effectors binding at sites distinct from the active site, causing conformational changes that alter the enzyme's catalytic efficiency. This provides a rapid, reversible mechanism for regulating metabolic pathways in response to changing cellular needs, with negative feedback being one of the most common control mechanisms in metabolism.</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 62.</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 62.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ec0176ba",
      "audio": ""
    },
    {
      "text": "Identify which of the following enzymes are considered hemoproteins.",
      "options": [
        {
          "label": "A",
          "text": "Nitric oxide synthase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tryptophan pyrrolase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both a & b",
          "correct": true
        },
        {
          "label": "D",
          "text": "None",
          "correct": false
        }
      ],
      "correct_answer": "C. Both a & b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Nitric oxide synthase: Correct , as it is a hemoprotein involved in the synthesis of nitric oxide.</li><li>\u2022 Option</li><li>\u2022 A. Nitric oxide synthase:</li><li>\u2022 Correct</li><li>\u2022 Option B. Tryptophan pyrrolase: Also correct, as it is a hemoprotein participating in the metabolism of tryptophan.</li><li>\u2022 Option</li><li>\u2022 B. Tryptophan pyrrolase:</li><li>\u2022 correct,</li><li>\u2022 Option D. None: Incorrect, as both listed enzymes are hemoproteins.</li><li>\u2022 Option</li><li>\u2022 D. None:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Heme is present in:</li><li>\u27a4 Hemoglobin Myoglobin Cytochromes Peroxidase Catalase Tryptophan pyrrolase Nitric oxide synthase</li><li>\u27a4 Hemoglobin</li><li>\u27a4 Myoglobin</li><li>\u27a4 Cytochromes</li><li>\u27a4 Peroxidase</li><li>\u27a4 Catalase</li><li>\u27a4 Tryptophan pyrrolase</li><li>\u27a4 Tryptophan pyrrolase</li><li>\u27a4 Nitric oxide synthase</li><li>\u27a4 Nitric oxide synthase</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 270.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 270.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "495f8edf",
      "audio": ""
    },
    {
      "text": "A 3-month-old infant with pale skin and blonde hair is presented to the pediatric outpatient department by her parents. The infant has two siblings with complete albinism, while both parents are phenotypically normal. Based on this family history and the clinical presentation, which statement is correct regarding albinism?",
      "options": [
        {
          "label": "A",
          "text": "Increased tyrosinase activity will be observed in melanocytes",
          "correct": false
        },
        {
          "label": "B",
          "text": "It results in photophobia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Mental retardation is the main characteristic feature in albinism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Skin has high pigmentation in albinism",
          "correct": false
        }
      ],
      "correct_answer": "B. It results in photophobia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increased tyrosinase activity: Incorrect. Albinism is usually associated with decreased or absent activity of tyrosinase in melanocytes, not increased activity.</li><li>\u2022 Option A. Increased tyrosinase activity:</li><li>\u2022 Option C. Mental retardation: Incorrect. Albinism does not inherently affect cognitive function; mental retardation is not a characteristic feature of albinism.</li><li>\u2022 Option</li><li>\u2022 C. Mental retardation:</li><li>\u2022 Option D. Skin has high pigmentation: Incorrect. Albinism is defined by reduced or absent pigmentation in the skin.</li><li>\u2022 Option</li><li>\u2022 D. Skin has high pigmentation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Albinism is characterized by a deficiency or absence of melanin pigmentation and can often result in photophobia due to the lack of melanin in the iris and retinal pigment epithelium. This causes increased light penetration into the eye, leading to discomfort in bright environments.</li><li>\u27a4 Ref : Vasudevan 9/ed: p 238.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/ed: p 238.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc67841e",
      "audio": ""
    },
    {
      "text": "Assertion (A): Cheesy odor in urine is mainly due to isovaleric acid excretion in urine, which is one of the intermediates formed during catabolism of leucine. Reasoning (R): The defective enzyme in isovaleric acidemia is isovaleryl CoA dehydrogenase which is a FAD + dependent enzyme. Which of the following is correct regarding the Assertion (A) and Reasoning (R)?",
      "options": [
        {
          "label": "A",
          "text": "A and R both are wrong",
          "correct": false
        },
        {
          "label": "B",
          "text": "A is a wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "C",
          "text": "A and R both are right but R is not the correct explanation of A",
          "correct": false
        },
        {
          "label": "D",
          "text": "A as well as R are right and R is a correct explanation of A",
          "correct": true
        }
      ],
      "correct_answer": "D. A as well as R are right and R is a correct explanation of A",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Isovaleric acidemia (FAD+ dependent enzyme) is a metabolic disorder characterized by the accumulation and excretion of isovaleric acid in the urine , which leads to the distinctive \"cheesy\" odor. This condition is due to a deficiency in isovaleryl CoA dehydrogenase, an enzyme crucial for the catabolism of leucine, an essential amino acid.</li><li>\u27a4 Isovaleric acidemia</li><li>\u27a4 metabolic disorder</li><li>\u27a4 accumulation</li><li>\u27a4 excretion of isovaleric acid in the urine</li><li>\u27a4 distinctive \"cheesy\" odor.</li><li>\u27a4 Ref : Harper 30/e: p 309-312.</li><li>\u27a4 Ref : Harper 30/e: p 309-312.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "681f35a9",
      "audio": ""
    },
    {
      "text": "A 62-year-old male presents with intermittent involuntary tremors in his left hand, difficulty feeding himself, walking challenges, and poor gait coordination for the past month. Upon examination, he exhibits a shuffling gait and resting tremors, but cognitive functions remain intact. Diagnosed with Parkinson's disease, he is prescribed levodopa. Which metabolic pathway is primarily affected in this condition?",
      "options": [
        {
          "label": "A",
          "text": "Phenylalanine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tryptophan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Histidine",
          "correct": false
        }
      ],
      "correct_answer": "C. Tyrosine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture8_lTZg06l.jpg"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Phenylalanine: While phenylalanine is a precursor to tyrosine , the direct pathway affected in Parkinson's disease is the tyrosine to dopamine pathway.</li><li>\u2022 Option</li><li>\u2022 A. Phenylalanine:</li><li>\u2022 precursor to tyrosine</li><li>\u2022 Option B. Tryptophan: Involved in the synthesis of serotonin and melatonin , not directly implicated in Parkinson's disease.</li><li>\u2022 Option</li><li>\u2022 B. Tryptophan:</li><li>\u2022 synthesis of serotonin and melatonin</li><li>\u2022 Option D. Histidine: Involved in the synthesis of histamine and is not directly related to the dopaminergic pathways affected in Parkinson's disease.</li><li>\u2022 Option</li><li>\u2022 D. Histidine:</li><li>\u2022 synthesis of histamine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Parkinson's disease is associated with the dopaminergic pathway , where tyrosine is a key precursor in the synthesis of dopamine. Levodopa , a precursor of dopamine , is used to increase dopamine levels in the brain, addressing the dopamine deficiency that characterizes Parkinson's disease.</li><li>\u27a4 Parkinson's disease</li><li>\u27a4 dopaminergic pathway</li><li>\u27a4 tyrosine</li><li>\u27a4 key precursor</li><li>\u27a4 synthesis of dopamine.</li><li>\u27a4 Levodopa</li><li>\u27a4 precursor of dopamine</li><li>\u27a4 increase dopamine levels</li><li>\u27a4 brain,</li><li>\u27a4 Parkinson's disease.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 235.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 235.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94095233",
      "audio": ""
    },
    {
      "text": "A 3-year-old male child presents with a 5-month history of eye ulceration and thick, rough, patchy skin on the palms and feet. Examination reveals dendritic corneal ulceration unresponsive to antiviral treatment and keratosis on the palms and plantar surfaces. Laboratory tests show increased levels of tyrosine in blood and urine. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Tyrosinemia type-2",
          "correct": true
        },
        {
          "label": "B",
          "text": "Tyrosinemia type-1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosinemia type-3",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hawkinsinuria",
          "correct": false
        }
      ],
      "correct_answer": "A. Tyrosinemia type-2",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture9.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I) is due to a deficiency of enzyme fumarylacetoacetate hydrolase . C/F: mild mental retardation, Cabbage like odour in urine, hypoglycemia liver failure and finally death occurs</li><li>\u2022 Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I)</li><li>\u2022 deficiency of enzyme fumarylacetoacetate hydrolase</li><li>\u2022 Option C. Neonatal Tyrosinemia (Tyrosinemia Type III) due to the absence of the enzyme para-hydroxyphenylpyruvate hydroxylase , which causes transient hypertyrosinemia in the newborn , and this will respond to ascorbic acid and dietary protein restriction.</li><li>\u2022 Option C. Neonatal Tyrosinemia (Tyrosinemia Type III)</li><li>\u2022 absence</li><li>\u2022 enzyme para-hydroxyphenylpyruvate hydroxylase</li><li>\u2022 transient hypertyrosinemia</li><li>\u2022 newborn</li><li>\u2022 Option D. Hawkinsinuria is due to dysfunction of p-HPPA oxidase, characterized by excretion of hawkinsin in urine , a derivative of p-HPPA.</li><li>\u2022 Option D.</li><li>\u2022 Hawkinsinuria</li><li>\u2022 dysfunction of p-HPPA oxidase,</li><li>\u2022 excretion of hawkinsin in urine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tyrosinemia type-2, also known as Richner-Hanhart syndrome, is characterized by elevated levels of tyrosine which can lead to eye problems (like corneal ulcers), skin disorders (such as palmoplantar keratosis), and sometimes intellectual disability.</li><li>\u27a4 Tyrosinemia type-2,</li><li>\u27a4 Richner-Hanhart syndrome,</li><li>\u27a4 elevated levels of tyrosine</li><li>\u27a4 lead to eye problems</li><li>\u27a4 skin disorders</li><li>\u27a4 intellectual disability.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 239.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "79141b91",
      "audio": ""
    },
    {
      "text": "A newborn screening reveals elevated levels of branched-chain amino acids and their \u03b1-ketoacid derivatives, along with lactic acidosis. Which enzyme is likely affected by this disorder?",
      "options": [
        {
          "label": "A",
          "text": "\u03b1-ketoglutarate dehydrogenase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Isocitrate dehydrogenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Malate dehydrogenase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Succinate dehydrogenase",
          "correct": false
        }
      ],
      "correct_answer": "A. \u03b1-ketoglutarate dehydrogenase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture20.jpg"
      ],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Isocitrate dehydrogenase: While part of the Krebs cycle , this enzyme is less directly impacted by the conditions described in the scenario.</li><li>\u2022 Option</li><li>\u2022 B. Isocitrate dehydrogenase:</li><li>\u2022 part of the Krebs cycle</li><li>\u2022 less directly impacted</li><li>\u2022 Option C. Malate dehydrogenase: Also part of the Krebs cycle , but the scenario specifically suggests an issue more closely related to \u03b1-ketoglutarate dehydrogenase due to the link with branched-chain amino acid metabolism.</li><li>\u2022 Option</li><li>\u2022 C. Malate dehydrogenase:</li><li>\u2022 Krebs cycle</li><li>\u2022 Option D. Succinate dehydrogenase: This enzyme is part of both the Krebs cycle and the electron transport chain , but the described symptoms do not specifically implicate this enzyme.</li><li>\u2022 Option</li><li>\u2022 D. Succinate dehydrogenase:</li><li>\u2022 enzyme is part of both</li><li>\u2022 Krebs cycle</li><li>\u2022 electron transport chain</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Elevated branched-chain amino acids and their derivatives, along with lactic acidosis, suggest mitochondrial disruption, potentially due to Maple Syrup Urine Disease (MSUD), affecting the Krebs cycle. Excess NADH from MSUD inhibits key enzymes like \u03b1-ketoglutarate dehydrogenase, leading to lactic acidosis by diverting pyruvate to lactate.</li><li>\u27a4 Elevated branched-chain amino acids</li><li>\u27a4 lactic acidosis,</li><li>\u27a4 mitochondrial disruption,</li><li>\u27a4 Maple Syrup Urine Disease</li><li>\u27a4 Krebs cycle.</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 208, 230, 431.</li><li>\u27a4 Ref</li><li>\u27a4 :  DM Vasudevan 9/e: p 208, 230, 431.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10aa33ba",
      "audio": ""
    },
    {
      "text": "A 7-month-old baby, with a family history of a urea cycle disorder leading to the death of a sibling at 1 year of age, has been diagnosed with the same condition. What is the rationale for administering benzoic acid to individuals with a urea cycle enzyme defect?",
      "options": [
        {
          "label": "A",
          "text": "It provides an alternative route for N 2 excretion through glycine conjugate, hippuric acid",
          "correct": true
        },
        {
          "label": "B",
          "text": "It provides an alternative route for N 2 excretion through the N-acetyl glucuronic acid conjugate kynurenine",
          "correct": false
        },
        {
          "label": "C",
          "text": "It inhibits adenylate deaminase",
          "correct": false
        },
        {
          "label": "D",
          "text": "It neutralized NH 3 in both blood as well as urine",
          "correct": false
        }
      ],
      "correct_answer": "A. It provides an alternative route for N 2 excretion through glycine conjugate, hippuric acid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. It provides an alternative route for nitrogen (N2) excretion through the N-acetyl glucuronic acid conjugate kynurenine: This option is not accurate; kynurenine is a metabolite in the tryptophan degradation pathway and not directly related to the excretion of nitrogen in the context of urea cycle disorders.</li><li>\u2022 Option</li><li>\u2022 B.</li><li>\u2022 Option C. It inhibits adenylate deaminase: Adenylate deaminase is not directly relevant to the management of urea cycle disorders or the mechanism of action of benzoic acid in these conditions.</li><li>\u2022 Option</li><li>\u2022 C.</li><li>\u2022 Option D. It neutralizes ammonia (NH3) in both blood and urine: Benzoic acid does not neutralize ammonia directly; instead, it provides an alternative pathway for nitrogen excretion by forming hippuric acid with glycine.</li><li>\u2022 Option</li><li>\u2022 D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In urea cycle disorders, benzoic acid provides an alternative pathway for nitrogen excretion by forming hippuric acid with glycine, thus reducing ammonia levels in the body. This is crucial for managing hyperammonemia resulting from the body's impaired ability to convert ammonia to urea.</li><li>\u27a4 Ref : DM Vasudevan 9/e: page 206.</li><li>\u27a4 Ref : DM Vasudevan 9/e: page 206.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e1766eef",
      "audio": ""
    },
    {
      "text": "A neonate is lethargic, drowsy, and irritable with blood analysis showing hyperammonemia and orotic aciduria. Considering this patient, orotic acid levels are high due to which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ammonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated glutamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bypassing carbamoyl phosphate synthetase II (CPS-II)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Bypassing aspartate transcarbamoylase",
          "correct": false
        }
      ],
      "correct_answer": "C. Bypassing carbamoyl phosphate synthetase II (CPS-II)",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture50.jpg"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A, Option B. The elevated ammonia is not a substrate of CPS-II and which glutamine is also elevated and is a substrate of CPS-II, higher glutamine concentrations will not overcome enzyme inhibition by its allosteric inhibitor, UTP.</li><li>\u2022 Option A, Option B.</li><li>\u2022 elevated ammonia</li><li>\u2022 not</li><li>\u2022 substrate of CPS-II</li><li>\u2022 glutamine is also elevated</li><li>\u2022 Option D. Aspartate transcarbamoylase is the regulated step of pyrimidine biosynthesis in many prokaryotic cells , but not in humans. This step is necessary for pyrimidines to be synthesized starting with carbamoyl phosphate.</li><li>\u2022 Option D.</li><li>\u2022 Aspartate transcarbamoylase</li><li>\u2022 regulated step of pyrimidine biosynthesis</li><li>\u2022 prokaryotic cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hyperammonemia and orotic aciduria in a neonate suggest a urea cycle defect, particularly ornithine transcarbamylase deficiency , leading to the diversion of carbamoyl phosphate into the pyrimidine synthesis pathway and bypassing CPS-II.</li><li>\u27a4 Hyperammonemia</li><li>\u27a4 orotic aciduria</li><li>\u27a4 neonate</li><li>\u27a4 urea cycle defect,</li><li>\u27a4 ornithine transcarbamylase deficiency</li><li>\u27a4 diversion of carbamoyl phosphate</li><li>\u27a4 pyrimidine synthesis pathway</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6dc5e6ab",
      "audio": ""
    },
    {
      "text": "A 22-year-old male avid marathon runner presents to the clinic with fatigue and mild disorientation after long training sessions. Laboratory tests indicate slightly elevated ammonia levels. Given the patient's high level of physical activity, the physician considers the main route of ammonia transport from his skeletal muscles to the liver for detoxification. What is the primary form in which ammonia is transported in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "Glutamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alanine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Both a and b",
          "correct": false
        },
        {
          "label": "D",
          "text": "None",
          "correct": false
        }
      ],
      "correct_answer": "B. Alanine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture70_0cAP8yW.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Glutamine: While glutamine is a significant carrier of ammonia, particularly in the brain and other tissues , in the context of intense physical activity, alanine plays a more direct role in transporting ammonia from muscles due to its involvement in the alanine-glucose cycle.</li><li>\u2022 Option</li><li>\u2022 A. Glutamine:</li><li>\u2022 carrier of ammonia,</li><li>\u2022 brain and other tissues</li><li>\u2022 Option C. Both A and B: Although glutamine does play a role in ammonia transport , the primary form under conditions of intense physical activity, like marathon running, is alanine due to the rapid generation and need for detoxification of ammonia.</li><li>\u2022 Option</li><li>\u2022 C. Both A and B:</li><li>\u2022 glutamine</li><li>\u2022 role in ammonia transport</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 During intense physical activity , alanine serves as the primary transporter of ammonia from skeletal muscle to the liver for detoxification , via the alanine-glucose cycle</li><li>\u27a4 intense physical activity</li><li>\u27a4 alanine</li><li>\u27a4 primary transporter of ammonia</li><li>\u27a4 skeletal muscle</li><li>\u27a4 liver for detoxification</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 203.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 203.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1053d34e",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a diagnosis of beriberi is found to have a deficiency in thiamine, a vital nutrient in her diet. Her physician explains the significance of thiamine as it relates to her condition and its role in enzymatic processes within the body. Based on this, which of the following best characterizes coenzymes like thiamine in their role in enzymatic reactions?",
      "options": [
        {
          "label": "A",
          "text": "Heat stable, dialyzable, non protein organic molecules",
          "correct": true
        },
        {
          "label": "B",
          "text": "Soluble, colloidal, protein molecules",
          "correct": false
        },
        {
          "label": "C",
          "text": "Structural analog of enzymes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Different forms of enzymes",
          "correct": false
        }
      ],
      "correct_answer": "A. Heat stable, dialyzable, non protein organic molecules",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Soluble, colloidal, protein molecules: This description more accurately pertains to enzymes themselves, which are proteinaceous in nature , rather than coenzymes. Coenzymes are not proteins but work alongside enzymes.</li><li>\u2022 Option B. Soluble, colloidal, protein molecules:</li><li>\u2022 accurately pertains to enzymes themselves,</li><li>\u2022 proteinaceous in nature</li><li>\u2022 Option C. Structural analog of enzymes: Coenzymes are not structural analogs of enzymes. Instead, they are distinct molecules that assist the catalytic activity of enzymes.</li><li>\u2022 Option C. Structural analog of enzymes:</li><li>\u2022 Coenzymes</li><li>\u2022 not structural analogs of enzymes.</li><li>\u2022 Option D. Different forms of enzymes: Coenzymes are not alternative forms of enzymes . They are separate, non-protein entities that bind to enzymes and participate in the catalytic process.</li><li>\u2022 Option D. Different forms of enzymes:</li><li>\u2022 Coenzymes</li><li>\u2022 not alternative forms of enzymes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Coenzymes are typically small , heat-stable , non-protein organic molecules that assist enzymes in catalyzing reactions . They often function as carriers of electrons , atoms , or functional groups . Being dialyzable, they can pass through semi-permeable membranes , which is not characteristic of larger protein molecules.</li><li>\u27a4 Coenzymes</li><li>\u27a4 typically small</li><li>\u27a4 heat-stable</li><li>\u27a4 non-protein organic molecules</li><li>\u27a4 assist enzymes in catalyzing reactions</li><li>\u27a4 function</li><li>\u27a4 carriers of electrons</li><li>\u27a4 atoms</li><li>\u27a4 functional groups</li><li>\u27a4 dialyzable,</li><li>\u27a4 pass through semi-permeable membranes</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 49, 50.</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 49, 50.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6b8d88bb",
      "audio": ""
    }
  ]
}